Section 31

EurekaMag Full Text Articles Chapter 30,107


Dixit, P.K.; Morgan, C.R.; Lowe, I.P.; Lazarow, A. 1963: Antiinsulin serum hyperglycemia: effect on in vitro glucose utilization and insulin degradation by rat epididymal fat pad. Metabolism, Clinical and Experimental 12: 642-651
Paul, L.C.; Davidoff, A.; Laverty, D.; Benediktsson, H.; Issekutz, T. 1993: Anti-integrin monoclonal antibodies influence graft vasculitis in acute cardiac graft rejection. Clinical and Investigative Medicine 16(4 Suppl): B137
Hines, D.; Fritz, L.; Yednock, T.; Setler, P.; Horner, H. 1993: Anti-intercellular cell adhesion molecule antibody reduces myeloperoxidase activity in rat head injury. Society for Neuroscience Abstracts 19(1-3): 1875
Gonzalez, R.; Ferrero, J.; Morales, M.G.; Aguilera, A.; Lopez Saura, P. 1997: Anti-interferon alpha antibodies before and after treatment with recombinant alpha-2B or natural, leukocyte alpha interferons. Journal of Interferon and Cytokine Research 17(Suppl 2): S107
Antonelli, G.; Dianzani, F. 1992: Anti-interferon antibodies in chronic hepatitis patients treated with different interferon alpha preparations. Journal of Hepatology 17(Suppl 1): S19
Bonetti, P.; Chemello, L.; Diodati, G.; Alberti, A. 1993: Anti-interferon antibodies in patients with chronic hepatitis C treated with Alpha-2A-IFN. Journal of Hepatology 18(Suppl 1): S98-S99
Gilli, F.; Marnetto, F.; Caldano, M.; Valentino, P.; Granieri, L.; Di Sapio, A.; Capobianco, M.; Sala, A.; Malucchi, S.; Kappos, L.; Lindberg, R.L.P.; Bertolotto, A. 2007: Anti-interferon-beta neutralising activity is not entirely mediated by antibodies. Journal of Neuroimmunology 192(1-2): 198-205
Demina, T.L.; Buglak, A.B.; Bolieva, I.A.; Alekseeva, T.G.; Pashenkov, M.V.; Smirnova, N.F.; Boiko, A.N.; Gusev, E.I.; Skurkovich, B.; Skurkovich, S. 1997: Anti-interferon-gamma and anti-tumor necrosis factor-alpha antibodies reduce the rate of progression in secondary progressive multiple sclerosis. Cytokine 9(11): 898
Ogawa, T.; Ogawa, K.; Saito, E.; Fukuya, H. 1998: Anti-interleukin 1 beta monoclonal antibody prevents skin fibrosis in the tight-skin mouse. Arthritis and Rheumatism 41(9 Suppl): S279
Maguire, H.C.Jr.; Ketcha, K.A.; Lattime, E.C. 1996: Anti-interleukin 10 antibody in a mouse is an immunoadjuvant for allergic contact dermatitis. Journal of Investigative Dermatology 106(4): 934
Kelly, J.L.; Soberg, C.C.; Lyons, A.; Mannick, J.A.; Lederer, J.A. 1997: Anti-interleukin 10 antibody treatment prevents burn injury induced T-cell anergy. Journal of Allergy and Clinical Immunology 99(1 Part 2): S367
Fuss, I.J.; Marth, T.; Pearlstein, G.; Neurath, M.; Strober, W. 1997: Anti-interleukin 12 regulates apoptosis of activated Th1 T cells in murine experimental granulomatous colitis. Gastroenterology 112(4 Suppl): A978
Cantarovich, D.; Hourmant, M.; Dantal, J.; Baatard, R.; Le Mauff, B.; Jacques, Y.; Paineau, J.; Murat, A.; Soulillou, J.P. 1993: Anti-interleukin 2 monoclonal antibody following simultaneous pancreatic and kidney transplantation: a randomized trial vs rabbit antithymocyte globulin. Transplantation Proceedings 25(1 Part 2): 1366
Hamelmann, E.; Cieslewicz, G.; Joetham, A.; Schwarze, J.; Gelfand, E.W. 1997: Anti-interleukin 5 but not anti-IgE treatment prevents airway inflammation and hyperresponsiveness. Journal of Allergy and Clinical Immunology 99(1 Part 2): S120
Yamamoto, M.; Ito, H.; Kanazawa, S.; Ogawa, H.; Nakamura, H.; Kishimoto, T. 1998: Anti-interleukin 6 receptor mAB prevents chronic intestinal inflammation in SCID mice reconstituted with CD4+ CD45Rbhigh T cells. Gastroenterology 114(4 Part 2): A1118
Garin, E.H.; Chandler, L. 1995: Anti-interleukin 8 neutralizing antibody abolishes proteinuria induced in vivo by supernatant factor from minimal change patients in relapse. Journal of the American Society of Nephrology 6(3): 418
Garin, E.H. 1996: Anti-interleukin 8 neutralizing antibody abolishes the in vivo effect of supernatant factor from minimal change patients in relapse on albuminuria and glomerular basement membrane 35S uptake. Pediatric Research 39(4 Part 2): 360A
Allendoerfer, R.; Deepe, G.S.Jr 1996: Anti-interleukin-12 antibody alters murine pulmonary histoplasmosis. Abstracts of the General Meeting of the American Society for Microbiology 96: 92
Gharaee Kermani, M.; Mcgarry, B.; Hufnagle, G.; Phan, S.H. 1997: Anti-interleukin-5 antibody inhibits bleomycin-induced pulmonary fibrosis and lung eosinophila. FASEB Journal 11(3): A228
Kriesel, J.D.; Hwang, I.P.; Maulden, S.A.; Dowell, T.A.; Clinch, T.E.; Araneo, B.A. 1996: Anti-interleukin-6 antibodies decrease the measured herpes simplex virus type-1 reactivation rate. IOVS Investigative Ophthalmology and Visual Science 37(3): S953
Matsuyama, M.; Suzuki, T.; Tsuboi, H.; Ito, S.; Mamura, M.; Goto, D.; Matsumoto, I.; Tsutsumi, A.; Sumida, T. 2007: Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman's disease. Internal Medicine 46(11): 771-774
Clark, D.R.; Deluca, D. 1993: Anti-interleukin-7 inhibits the development of CD3-negative thymocytes in murine fetal thymus/fetal liver organ culture chimeras. Journal of Immunology 150(8 Part 2): 108A
Duthinh, P. 1996: Anti-intoxication composition. Official Gazette of the United States Patent and Trademark Office Patents 1189(3): 1990
Amato, A.A.; Brey, R.L.; Rhine, C.B.; Stallworth, C.; Kagan Hallet, K. 1997: Anti-intracellular adhesion molecule-1 antibody therapy in prevention of peripheral nervous system abnormalities in Lupus-prone mice. Neurology 48(3 Suppl 2): A363
Abrams, P.; Vertommen, J.; De Leeuw, I.; Registry, The Belgian Diabetes 1994: Anti-intrinsic-factor antibodies and anti-parietal-cell auto-antibodies in newly-diagnosed insulin-dependent diabetic patients. Diabetologia 37(Suppl 1): A91
Rao, J.; Chintala, S.; Venkaiah, B.; Gomez Manzano, C.; Fueyo, J.; Kyritsis, A. 1997: Anti-invasion effect of p16 in malignant glioma. Proceedings of the American Association for Cancer Research 38: 567
Kim, K.W.; Cha, H.J.; Bae, S.K.; Lee, H.Y.; Lee, O.H.; Sato, H.; Seiki, M.; Park, B.C. 1996: Anti-invasive activity of ursolic acid in the HT1080 human fibrosarcoma cells. Proceedings of the American Association for Cancer Research 37: 74
Mareel, M.; Dierckx, R.; De Neve, W. 1998: Anti-invasive brain tumor therapy General aspects and future strategies. Mikkelsen, T , Bjerkvig, R , Laerum, O D , Rosenblum, M L Brain tumor invasion: Biological, clinical, and therapeutic considerations 391-414
Mikkelsen, T.; Edvardsen, K.; Nelson, K.; Bjerkvig, R.; Smith, R.; Rasnick, D.; Sloane, B.; Palmer, J.; Zimmerman, M. 1996: Anti-invasive effects of cysteine protease inhibitors in a 3D glioma confrontation model. Proceedings of the American Association for Cancer Research 37: 80
Mocanu, M.M.; Baxter, G.F.; Yellon, D.M. 1998: Anti-ischaemic action of transforming growth factor beta-1 in the rat isolated heart is abolished by the p38 MAPK inhibitor SB203580. British Journal of Pharmacology 123(Proceedings Suppl ): 333P
Acharya, D.U.; Senior, R.; Basu, S.; Harrison, F.; Galiano, A.; Lahiri, A. 1994: Anti-ischaemic and haemodynamic effects of elgodipine, a potent new generation calcium antagonist, in chronic stable angina. European Heart Journal 15(5): 665-671
Zehender, M.; Glitza, N.; Faber, T.S.; Jeron, A.; Meinertz, T.; Just, H. 1997: Anti-ischaemic effects of intravenous nicorandil when directed to patients with documented myocardial ischaemia undergoing percutaneous transluminal coronary angioplasty. European Heart Journal 18(ABSTR Suppl ): 165
Awad, W.I.; Chambers, D.J.; Shattock, M.J. 1998: Anti-ischaemic effects of mitochondrial vs sarcolemmal KATP channel openers in adult and neonatal rat heart. Journal of Molecular and Cellular Cardiology 30(6): A138
Jespersen, C.M. 1995: Anti-ischaemic intervention with verapamil in patients recovering from acute myocardial infarction. European Heart Journal 16 Suppl H: 13-17
Boden, W.E. 1996: Anti-ischaemic therapy during the follow-up phase of acute coronary syndromes. Is there a role for calcium channel blockers?. Drugs 52(Suppl 4): 20-30
Vered, M.; Bar-Joseph, A.; Belayev, L.; Berkovich, Y.; Biegon, A. 1994: Anti-ischemia activity of HU-211, a non-psychotropic synthetic cannabinoid. Acta Neurochirurgica. Supplementum 60: 335-337
Takase, Y.; Watanabe, N.; Matsui, M.; Ikuta, H.; Kimura, T.; Saeki, T.; Adachi, H.; Tokumura, T.; Mochida, H.; Akita, Y.; Souda, S. 1996: Anti-ischemic 2,4-diaminoquinazolines. Official Gazette of the United States Patent and Trademark Office Patents 1192(3): 2063
Nikitin, Y..; Kurilovich, V. 1993: Anti-ischemic activity of diltiazem and nifedipine in combination with long-acting nitrates in non-Q wave myocardial infarction A randomized single-blind trial. Cardiovascular Drugs and Therapy 7(Suppl 2): 458
Pan, W.; Mullane, K.; Young, M. 1993: Anti-ischemic activity of the novel adenosine regulating agent, GP-1-468, in a canine model of stable angina. FASEB Journal 7(3-4): A119
Sugiyama, A.; Ishida, Y.; Sawada, N.; Hashimoto, K. 1997: Anti-ischemic and cardiovascular effects of CP-060S. Japanese Journal of Pharmacology 73(Suppl 1): 72P
Shinohara, T.; Kawahara, K.; Nakajima, T. 1994: Anti-ischemic effect of Y-27152, a new K+ channel opener, in a canine model of exercised angina pectoris. Japanese Journal of Pharmacology 64(Suppl 1): 266P
Shukla, P.K.; Khanna, V.K.; Ali, M.M.; Khan, M.Y.; Srimal, R.C. 2008: Anti-ischemic effect of curcumin in rat brain. Neurochemical Research 33(6): 1036-1043
Okubo, S.; Shah, V.; Kukreja, R.C. 1998: Anti-ischemic effect of mu-adrenergic stimulation is mediated by tyrosine kinase-dependent mechanism. Circulation 98(17): I586
Marni, A.; Forti, D.; Calvillo, L.; Gaja, G.; Ferrero, M.E. 1996: Anti-ischemic effect of oligotide treatment in rat kidney: comparison with the effect of nifedipine and isosorbide dinitrate. Transplantation Proceedings 28(1): 301-303
Deedwania, P.C. 1993: Anti-ischemic effects of amiodipine in patients with stable coronary artery disease and ischemia during daily life. Journal of the American College of Cardiology 21(2 Suppl A): 253A
Van Den Heuvel, A.F.M.; Van Gilst, W.H.; Van Veldhuisen, D.J.; De Vries, R.J.M.; Dunselman, P.H.J.M.; Kingma, J.H. 1997: Anti-ischemic effects of angiotensin converting enzyme inhibition after myocardial infarction. Cardiovascular Drugs and Therapy 11(Suppl 2): 400
Acharya, D.; Basu, S.; Senior, R.; Raftery, E.B.; Lahiri, A. 1993: Anti-ischemic effects of elgodipine. Cardiovascular Drugs and Therapy 7(Suppl 2): 433
Verscheure, Y.G. Pouget; Le Grand, B.; John, G.W. 1997: Anti-ischemic effects of novel inhibitor of the late sodium current Comparison with conventional sodium channel blockers. Journal of Molecular and Cellular Cardiology 29(5): A77
Ponchaut, S.; Goudemant, J.F.; Demeure, R.; Vanoverschelde, J.L.; Hue, L. 1998: Anti-ischemic effects of trimetazidine 31P- and 23Na-NMR spectroscopy in the working rat heart. Journal of Molecular and Cellular Cardiology 30(6): A9
Kim, J.H.; Kang, J.K. 1993: Anti-ischemic efficacy of 21-aminosteroid U-74006F in focal cerebral infarction in rats. Journal of Catholic Medical College 46(3): 907-917
Kaji, T.; Kohya, T.; Tomita, F.; Ono, T.; Itoh, Y.; Kitabatake, A. 1997: Anti-ischemic efficacy of beta-blockers in effort angina patients is correlated with heart rate variability change after therapy. Journal of the American College of Cardiology 29(2 Suppl A): 252A
Haikala, H.O.; Levijoki, J.M.; Backstrom, R.J.; Nore, P.T.; Honkanen, E.J. 1996: Anti-ischemic medicament. Official Gazette of the United States Patent and Trademark Office Patents 1185(5): 3532-3533
Greaves, M.W. 1997: Anti-itch treatments: do they work?. Skin Pharmacology: the Official Journal of the Skin Pharmacology Society 10(5-6): 225-229
Locht, H.; Peen, E.; Skogh, T. 1994: Anti-lactoferrin antibodies and other types of anti-neutrophil cytoplasm antibodies in reactive arthritis and ankylosing spondylitis. Arthritis and Rheumatism 37(9 Suppl): S204
Coremans, I.E.M.; Hagen, E.C.; Daha, M.R.; Van Der Woude, F.J.; Van Der Voort, E.A.M.; Breedveld, F.C. 1993: Anti-lactoferrin antibodies in patients with Feltys syndrome. Clinical and Experimental Immunology 93(Suppl 1): 33
Balacco Gabrieli, C.; Caccavo, D.; Di Monaco, C.; Giorgi, D.; Giorgi, A.; Bonomo, L. 1998: Anti-lactoferrin antibodies in uveitis. IOVS Investigative Ophthalmology and Visual Science 39(4): S360
Peen, E.; Sundquist, T.; Skogh, T. 1998: Anti-lactoferrin-antibody-mediated activation of granulocytes on cultured bovine aorta endothelial cells induces macromolecular leakage over the endothelial cells. Clinical and Experimental Immunology 112(Suppl 1): 46
Lazarova, Z.; Yee, C.; Cheng, P.; Yancey, K. 1996: Anti-laminin 5 IgG induces subepidermal blisters in adult murine skin as well as human skin grafted onto SCID mice. Journal of Investigative Dermatology 106(4): 812
Zinkl, G.M.; Zuk, A.; Matlin, K.S. 1994: Anti-laminin adhesion antibody delays MDCK cell polarization and tight junction formation. Molecular Biology of the Cell 5(Suppl ): 180A
Petri, M.; Aramli, L.A.; Baldwin, M.T.; Klein, N.W.; Kleinman, H.K. 1995: Anti-laminin antibodies in lupus pregnancy. Arthritis and Rheumatism 38(9 Suppl): S219
Church, H.J.; Jones, T.; Aplin, J.D. 1997: Anti-laminin autoantibodies in recurrent miscarriage patients. Placenta 18(5-6): A17
Yoshida, M.; Tonasaki, A. 1993: Anti-lamprey retinal antibodies Short and long photoreceptor-specific antibodies. Anatomical Record 1993(Suppl 1): 123
Worth, H.N.; Subrahmanyam, K. 1940: Anti-larval flushing of rivers and streams in Ceylon. Jour Malaria Inst India 3(1): 81-92
Rice, E.Milford 1935: Anti-larval oil application by a one man brushing method. Rec Malaria Surv India 5(4): 499-500
Hori, Y.; Joki, H.N.; Kaname, S.; Fukagawa, M.; Okuda, T.; Ohashi, H.; Katoh, T.; Fujita, T.; Miyazono, K.; Kurokawa, K. 1996: Anti-latent transforming growth factor-beta binding protein antibody or synthesized oligopeptides inhibit extracellular matrix expression induced by stretch in cultured rat mesangial cells. Journal of the American Society of Nephrology 7(9): 1856
Charous, B.L.; Steven, G.C.; Beezhold, D.H. 1995: Anti-latex IgE specificity does not correlate with clinical history. Journal of Allergy and Clinical Immunology 95(1 Part 2): 157
Croft, S.L. 1992: Anti-leishmanial and anti-trypanosomal activities of hydroxynaphthoquinones, phospholipid analogues and amphotericin B liposomes. Memorias do Instituto Oswaldo Cruz 87(Suppl 2): 74-75
Burguete,A.; Estevez,Y.; Castillo,D.; Gonzalez,G.; Villar,R.; Solano,B.; Vicente,E.; Silanes,S.P.; Aldana,I.; Monge,A.; Sauvain,M.; Deharo,E. 2008: Anti-leishmanial and structure-activity relationship of ring substituted 3-phenyl-1- -2-propen-1-one derivatives. Memorias do Instituto Oswaldo Cruz 103(8): 778-780
Lindoso, J.A.L.; Gidlund, M.; Goto, H. 1997: Anti-leishmanial drug has oxidative effect on low density lipoprotein and progression of visceral leishmaniasis. Memorias do Instituto Oswaldo Cruz 92(Suppl 1): 117
Azazy,A.A.; Al-Shibani,L.A.; Mohammad,A.E. 2008: Anti-leishmanial polyclonal antibodies to assess the performance characteristics of leishmanial antigen detection ELISA. Journal Of The Egyptian Society Of Parasitology: 3, 1027-1036
Hackett, E.; Thompson, A. 1964: Anti-Lens Antibody in Human Sera. Lancet 2(7361): 663-666
Miller, W.J. 1958: Anti-lens sera as a mutagen in rabbits. Journal of Experimental Zoology 137(3): 463-477
Barbosa, M. 1962: Anti-leptospira agglutinins and lysins in cattle, horse and swine sera in Mina Gerais, Brazil. Arq Escol Veterinaria Univ Minas Gerais Belu Horizonte 14: 1-26
Mori, I.; Nagano, T.; Taiji, M.; Noguchi, H. 1997: Anti-lethal effect of hepatocyte growth factor on glycerol-injected rats. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 592A
Banffer, J.R. 1962: Anti-leucocidin and mastitis puerperalis. British Medical Journal 2(5314): 1224-1226
Bagdasarov, A.A.; Dvolaitskaia Barysheva, K.M.; Bolotnikova, F.I.; Bogoiavlenskaia, M.P.; Fainshtein, F.E. 1958: Anti-leucocyte antibodies in hypoplastic anaemia and chronic radiation sickness. Problemy Hematol I Perel Krovi transl 3(4): 217-222
Thiersch, J.B. 1942: Anti-leucocytic sheep serum as sensitizing agent in chronic myeloid leucemia refractory to deep x-ray therapy. Med Jour Australia 29(8): 225-229
Velardi, A.; Albi, N.; Ruggeri, L.; Volpi, I.; Capanni, M.; Casucci, M.; Piselli, M.; Tosti, A.; Aversa, F.; Martelli, M.F. 1996: Anti-leukemia T cell-mediated immunity in recipients of mismatched stem cell transplants. Blood 88(10 Suppl 1 Part 1-2): 267A
Kikuchi, H.; Oshima, Y.; Ichimura, A.; Gokan, N.; Hasegawa, A.; Hosaka, K.; Kubohara, Y. 2006: Anti-leukemic activities of Dictyostelium secondary metabolites: a novel aromatic metabolite, 4-methyl-5-n-pentylbenzene-1,3-diol, isolated from Dictyostelium mucoroides suppresses cell growth in human leukemia K562 and HL-60 cells. Life Sciences 80(2): 160-165
Wong, E.; Eaves, C.; Phillips, G.L.; Klingemann, H.G. 1994: Anti-leukemic activities of human bone marrow and blood cells after culture in IL-2, IL-7 and IL-12. Experimental Hematology 22(8): 826
Doukas, M.; Gass, C.; Chavan, A.; Pendergrass, K.; Nickel, P.; Boone, T.; Haley, B. 1998: Anti-leukemic activities of suramin analogs correlate with granulocyte/macrophage-colony stimulating factor nucleotide binding site interactions. Proceedings of the American Association for Cancer Research 39: 656
Gautam, S.C.; Pindolia, K.R.; Xu, Y.X.; Chapman, R.A.; Janakiraman, N. 1997: Anti-leukemic activity of TNF-alpha gene therapy against minimal residual disease. Cancer Gene Therapy 4(6 CONF Suppl ): S38
Miller, J.J.; Olds, L.C. 1993: Anti-lipid A antibody in juvenile arthritis Cross-reactions with auto-antigens. Journal of Rheumatology 20(Suppl 37): 57
Thomson, G.T.D.; Alfa, M.; Orr, K.; Thomson, B.R.J.; Olson, N. 1992: Anti-lipopolysaccharide antibodies as a serologic test for reactive arthritis. Arthritis and Rheumatism 35(9 Suppl): S353
Ohl, C.A.; Pollack, M. 1996: Anti-lipopolysaccharide antibodies modulate proinflammatory LPS-leukocyte interactions. Journal of Endotoxin Research 3(Suppl 1): 8
Di Padova, F.E.; Mikol, V.; Barclay, G.R.; Poxton, I.R.; Brade, H.; Rietschel, E.T. 1994: Anti-lipopolysaccharide core antibodies. Progress in Clinical and Biological Research 388: 85-94
De la Vega, E.; O'Leary, N.A.; Shockey, J.E.; Robalino, J.; Payne, C.; Browdy, C.L.; Warr, G.W.; Gross, P.S. 2008: Anti-lipopolysaccharide factor in Litopenaeus vannamei (LvALF): a broad spectrum antimicrobial peptide essential for shrimp immunity against bacterial and fungal infection. Molecular Immunology 45(7): 1916-1925
Vega,E.dela; O'Leary,N.A.; Shockey,J.E.; Robalino,J.; Payne,C.; Browdy,C.L.; Warr,G.W.; Gross,P.S. 2008: Anti-lipopolysaccharide factor in Litopenaeus vannamei a broad spectrum antimicrobial peptide essential for shrimp immunity against bacterial and fungal infection. Molecular Immunology: 7, -1925
Tharntada, S.; Somboonwiwat, K.; Rimphanitchayakit, V.; Tassanakajon, A. 2008: Anti-lipopolysaccharide factors from the black tiger shrimp, Penaeus monodon, are encoded by two genomic loci. Fish and Shellfish Immunology 24(1): 46-54
Teti, G.; Mancuso, G.; Tomasello, F.; Ofek, I. 1993: Anti-lipoteichoic acid antibodies enhance the release of cytokines by monocytes sensitized with lipoteichoic acid. Abstracts of the General Meeting of the American Society for Microbiology 93: 144
Dortu, C.; Huch, M.; Holzapfel, W.H.; Franz, C.M.A.P.; Thonart, P. 2008: Anti-listerial activity of bacteriocin-producing Lactobacillus curvatus CWBI-B28 and Lactobacillus sakei CWBI-B1365 on raw beef and poultry meat. Letters in Applied Microbiology 47(6): 581-586
Edelson, B.T.; Cossart, P.; Unanue, E.R. 1998: Anti-listeriolysin O monoclonal antibody reduces lymphocyte apoptosis during early phase of Listeria infection in mice. FASEB Journal 12(4): A573
Mafune, N.; Kobayashi, K.; Ikemoto, M.; Sasaki, M.; Tanaka, A.; Ozawa, K.; Totani, M.; Ueda, K.; Mori, T. 1994: Anti-liver arginase autoantibody A prognostic marker for liver transplantation?. Tscuhiya, M , Yodoi, J , Hibi, T , Miura, S International Congress Series; Current topics in mucosal immunology, 1993 243-248
Rake, G.; Jones, H.; Mckee, C.M. 1943: Anti-luminescent activity of antibiotic substances. Proceedings Society Exp Biol and Med 52(2): 136-138
Iwasaki, K.I.; Makino, T.; Maruyama, T.; Umeuchi, M.; Matsubayashi, H.; Nozawa, S. 1992: Anti-lymphocyte antibodies against fetal lymphocytes by flow cytometric crossmatch during pregnancy. EOS-Rivista di Immunologia ed Immunofarmacologia 12(2): 103
Mueller, C.; Kukel, S.; Schneweis, K.E.; Bauer, R. 1993: Anti-lymphocyte antibodies in HIV-1 infected patients preferentially react with MHC class II negative T cells and are possibly induced by gp41. IXTH INTERNATIONAL CONFERENCE ON AIDS and THE IVTH STD WORLD CONGRESS Author IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 206
Szczech, L.; Berlin, J.; Feldman, H. 1997: Anti-lymphocyte antibody induction therapy and renal allograft survival A meta-analysis of patient-level data. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 705A
Ardern-Jones, M.R.; Black, A.P.; Ogg, G.S. 2008: Anti-lymphocyte function associated antigen-1 inhibits T-helper 2 function of human allergen-specific CD4+ T cells. British Journal of Dermatology 158(3): 456-462
Brendel, W. 1967: Anti-lymphocyte serum Better success with transplants. Umschau Wiss Tech: 24-25
Chew, W.B.; Lawrence, J.S. 1937: Anti-lymphocytic serum. Jour Immunol 33(4): 271-278
Orth, T.; Schwarting, A.; Meyer Zum Bueschenfelde, K.H.; Mayet, W.J. 1996: Anti-lymphocytotoxic-antibodies and antineutrophil-cytoplasmic-antibodies in patients with primary sclerosing cholangitis. Journal of Hepatology 25(Suppl 1): 182
Comacchio, R.M.; Williams, W.M.; Morrow, M.J.W. 1996: Anti-lymphyocyte antibodies in HIV infection Epitope mapping of anti-histone H2B antibodies. ELEVENTH INTERNATIONAL CONFERENCE ON AIDS Eleventh International Conference on AIDS, Vol Two One world: One hope : 267-268
D.Costa Cruz, J. 1926: Anti-lytic action of bactericidal serum in bacteriolysis by the bacteriophage. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 95: 1006-1007
Feng, L.; Xia, Y.; Yoshimura, T.; Wilson, C.B. 1994: Anti-macrophage inflammatory protein-2 antibody modulates Ab-induced glomerular neutrophil influx. Journal of the American Society of Nephrology 5(3): 746
Tanter, Y.; Renard, C.; Mousson, C.; Charfeddine, K.; Vaiman, M.; Rifle, G. 1992: Anti-major histocompatibility complex antibody removal assay in a swine model. Annales de Medecine Interne 143(Suppl 1): 43-47
Goerlitzer, K.; Stockmann, R.; Walter, R.D. 1995: Anti-malaria active 10 H-indolo quinoline-11-yl-amines Part 2 Chloroquine analogues. Pharmazie 50(2): 105-111
Rector, N.H. 1943: Anti-malaria ditching by dynamite. Jour Nation Malaria Soc 2(2): 11-20
Vogt, G.B. 1945: Anti-malaria mosquito work in Maryland. Proceedings Annual Meeting - new Jersey Mosquito Extermination Association 32: 251-253
Rebelo, Ant6nio 1945: Anti-malaria station Malaria in Quelimane. Mozambique Documentdrio Trimestral 44: 47-64
Hirayama, K.; Zaidi, M.A.S.; Lokman, H.S.; Joo, O.K.; Kikuchi, M.; Nasuruddin, H.A.; Kojima, S.; Wah, M.J. 1996: Anti-malarial HLA-B53 in Africa and common DNA types in Malaysian aborigines share a C-terminal pocket of peptide binding groove. Human Immunology 47(1-2): 118
Troye Blomberg, Marita 1997: Anti-malarial IgE A pathogenic factor in Plasmodium falciparum malaria. Immunology 92(Suppl 1): 76
Pessoa, S.B.; Sacramento, W. 1942: Anti-malarial action of resorcinol-quinine. Anais Paulistas Med E Cir 44(3): 232
Walker, J. 1951: Anti-malarial activity in 24-diamino-5-arylpyrimidines Some reactions of -formylphenylacetonitrile. Jour Chem Soc : 3439-3444
Oyewole,I.O.; Ibidapo,C.A.; Moronkola,D.O.; Oduola,A.O.; Adeoye,G.O.; Anyasor,G.N.; Obansa,J.A. 2008: Anti-malarial and repellent activities of Tithonia diversifolia leaf extracts. Journal Of Medicinal Plants Research: 8, 171-175
Wallace, S.; Bedu Addo, G.; Rutherford, T.; Bates, I. 1997: Anti-malarial antibodies in lymphoproliferative disorders in Africa. British Journal of Haematology 97(Suppl 1): 27
Nath, J.; Okoye, V.; Schneider, I. 1993: Anti-malarial effects of the anti-tubulin herbicide trifluralin Studies with Plasmodium falciparum. Molecular Biology of the Cell 4(Suppl ): 265A
Vivas, L.; Rattray, L.; Stewart, L.; Bongard, E.; Robinson, B.L.; Peters, W.; Croft, S.L. 2008: Anti-malarial efficacy of pyronaridine and artesunate in combination in vitro and in vivo. Acta Tropica 105(3): 222-228
Konstansov, S.V.; Anonymous 1929: Anti-malarial immunity, vaccine and vaccina-tion. Russian Journal of Tropical Medicine Med and Vet Parasitol 7(10): 645-657
Rigby, W. 1938: Anti-malarials I Derivatives of 4-acetoacetyl-6-methoxyquino-line. Quarterly Journal of Pharmacy and Pharmacology: 722-728
Wei, W.Z.; Gill, R.F.; Jones, R.; Fuji, H.; Abastado, J.P. 1995: Anti-mammary tumor cytolytic T lymphocytes induced with mouse mammary tumor virus envelope peptide E474. Proceedings of the American Association for Cancer Research 36: 477
Ecoma, E.E. 1967: Anti-measles mass immunization campaign. J Trop Pediat 13(2): 77-84
Cancellieri, V.; Sesana, B.M.; Della Rosa, C.; Negrelli, V.; Maspero, A. 1993: Anti-measles parotitis-rubella trivalent vaccination in neonates and in children attending the 5th grade of elementary school. Giornale di Malattie Infettive e Parassitarie 45(2): 169-172
Todescato, A.; Maggiore, A.; Giacobbo, M.; Sasso, L.D.; Stopazzolo, G.P. 1993: Anti-measles vaccination Frequency of side effects with different vaccinal strains. Giornale di Malattie Infettive e Parassitarie 45(2): 173-177
Moore, C.; Ehlayel, M.; Sorensen, R.U. 1995: Anti-meningococcal antibodies in recurrent meningococcal meningitis secondary to C5 deficiency. Journal of Allergy and Clinical Immunology 95(1 Part 2): 240
Jurand, A. 1963: Anti-Mesodermal Activity of a Nitrogen Mustard Derivative. Journal of Embryology and Experimental Morphology 11: 689-696
Hellstrom, I.; Friedman, E.; Verch, T.; Yang, Y.; Korach, J.; Jaffar, J.; Swisher, E.; Zhang, B.; Ben-Baruch, G.; Tan, M.C.B.; Goedegebuure, P.; Hellstrom, K.E. 2008: Anti-mesothelin antibodies and circulating mesothelin relate to the clinical state in ovarian cancer patients. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 17(6): 1520-1526
Johnston, R. 1963: Anti-metabolites as an aid to the study of phytoplankton nutrition. Jour Mar Biol Assoc United Kingdom 43(2): 409-425
Hurst, J.; Maniar, N.; Emma, D.; Thuning Roberson, C.; Lucas, F.; Steplewski, Z. 1994: Anti-metastatic activity index using a spontaneously metastasizing human mammary tumor xenograft model. Proceedings of the American Association for Cancer Research 35: 370
Flynn, C.; Bull, C.; Eberwein, D.; Matherne, C.; Hibner, B. 1998: Anti-metastatic activity of BAY 12-9566 in a human colon carcinoma HCT116 orthotopic model. Proceedings of the American Association for Cancer Research 39: 301
Barratt, G.; Puisieux, F.; Yu, W.P.; Foucher, C.; Fessi, H.; Devissaguet, J.P. 1994: Anti-metastatic activity of MDP-L-alanyl-cholesterol incorporated into various types of nanocapsules. International Journal of Immunopharmacology 16(5-6): 457-461
Suzuki, F.; Kobayashi, M.; Maeda, H.; Pollard, R.B. 1994: Anti-metastatic activity of SMANCS , a polymer-conjugated proteinaceous antibiotic neocarzinostatin, in mice bearing B16F10 melanoma. Proceedings of the American Association for Cancer Research 35: 399
Price, K.N.; Johnson, S.C.; Baker, D.C.; Chisena, T.; Cysyk, R.L. 1997: Anti-metastatic oligosaccharides and analogues from hyaluronic acid. Abstracts of Papers American Chemical Society 213(1-3): CARB 46
Park, T.Yoon.; Park, M.Hwan.; Shin, W.Cheol.; Rhee, M.Hee.; Seo, D.Wan.; Cho, J.Youl.; Kim, H.Mook. 2008: Anti-metastatic potential of ginsenoside Rp1, a novel ginsenoside derivative. Biological and Pharmaceutical Bulletin 31(9): 1802-1805
Blanock, K.; Jani, J.P.; Specht, S.; Stemmler, N.; Singh, S.V.; Gupta, V.; Katoh, A. 1994: Anti-metastatic potential of lovastatin, a cholesterol lowering drug. Proceedings of the American Association for Cancer Research 35: 51
Daneker, G.; Lund, S.; Caughman, W.; Wood, W. 1995: Anti-metastatic prostacyclins inhibit E-selectin mediated adhesion of colon carcinoma to endothelial cells. Journal of Cellular Biochemistry Suppl 1995(19B): 25
Nokihara, H.; Hanibuchi, M.; Yanagawa, H.; Shinohara, T.; Fujiki, F.; Nishinuraa, N.; Parajuli, P.; Tsuruo, T.; Sone, S. 1998: Anti-metastatic therapy of MDR human lung cancer with anti-P-glycoprotein antibody and monocyte chemoattractant protein-1 gene transduction in SCID mice. Proceedings of the American Association for Cancer Research 39: 440
Otsuka,N.; LiuMeiHua; Shiota,S.; Ogawa,W.; Kuroda,T.; Hatano,T.; Tsuchiya,T. 2008: Anti-methicillin resistant Staphylococcus aureus compounds isolated from Laurus nobilis. Biological and Pharmaceutical Bulletin: 9, 1794-1797
Guo, H.; Kubota, T.; Hoffman, R.M. 1994: Anti-methionine cancer therapy Ethionine is synergistic with methionine depletion for inducing a therapeutic tumor-selective pre-mitotic cell-cycle block. Proceedings of the American Association for Cancer Research 35: 469
Hoffman, R.M.; Tan, Y. 1996: Anti-methionine chemotherapy as a potential universal modulator for anti-tumor and anti-metastatic therapy. Clinical and Experimental Metastasis 14(Suppl 1): 85
Guo, H.; Kubota, T.; Hoffman, R.M. 1994: Anti-methionine chemotherapy induces a therapeutic tumor-specific cell-cycle block in vivo. Clinical and Experimental Metastasis 12(5): 93
Brodie, D.A.; Tye, A.; Nelson, J.W. 1955: Anti-metrazol efficacy of combinations of meparfynol and anticonvulsant drugs. Journal of the American Pharmaceutical Association. American Pharmaceutical Association 44(1): 59-61
Charnley, M.; Moir, A.J.G.; Douglas, C.W.I.; Haycock, J.W. 2008: Anti-microbial action of melanocortin peptides and identification of a novel X-Pro-D/L-Val sequence in Gram-positive and Gram-negative bacteria. Peptides 29(6): 1004-1009
Spivak, M.Y.; Argudyaeva, N.A.; Kono Shenko, M.F. 1963: Anti-microbial action of phytoncidin, a medicinal preparation from garlic. Antibiotiki 8(9): 832-833
WangQuanZhen; HuTianMing; XuYaMei 2008: Anti-microbial activities of root extracts of Cichorium intybus L. Multifunctional Grasslands In A Changing World, Volume Ii: Xxi International Grassland Congress And Viii International Rangeland Congress, Hohhot, China, 29 E 5 Y: 42
Goulet Miller, F.; Mott, J.B. 1998: Anti-microbial activity of bacteria isolated from epiphytic biofilms of marine algae. Abstracts of the General Meeting of the American Society for Microbiology 98: 388
Nagarajan,K.; AvijitMazumdar; Umadevi,G.; Jha,S.; Ghosh,L.K.; Prabha,K.S.; Nightingale,T.; Devaki,K. 2008: Anti-microbial activity of extracts and isolates of leaves of Acalypha canescana Linn. Hamdard Medicus: 2, 5-9
Hirata, M.; Kirikae, T.; Hirai, Y.; Yokota, K.; Suganuma, N.; Oguma, K.; Balint, R.F.; Wright, S.C.; Larrick, J.W. 1997: Anti-microbial and LPS-neutralizing synthetic peptides derived from human CAP18. FASEB Journal 11(9): A1452
Fife, R.K. 1995: Anti-microbial apparatus and method for dental handpieces. Official Gazette of the United States Patent and Trademark Office Patents 1173(3): 1809
Burrell, R.E.; Morris, L.R. 1998: Anti-microbial coating for medical device. Official Gazette of the United States Patent and Trademark Office Patents 1210(3): 2499
Mello Sampaio, C.; Pereira, S.; Peres, C. 1998: Anti-microbial components of lactic bacteria in oil Quality control of oil. Revista de Ciencias Agrarias 21(1-4): 357-362
SunAiDong; SunJianXia; BaiWeiBin; HuXiaoDan; SunHongNan 2008: Anti-microbial functions of apple polyphenols. Journal Of Beijing Forestry University: 4, 150-152
Lorina, M.; Rines, R.H.; Rines, C.M.; Rines, J.C. 1998: Anti-microbial herb/plant extractions. Official Gazette of the United States Patent and Trademark Office Patents 1213(2): 1756
Burrell, R.E.; Morris, L.R.; Apte, P.S.; Sant, S.B.; Gill, K.S. 1998: Anti-microbial materials. Official Gazette of the United States Patent and Trademark Office Patents 1216(3): 2845-2846
Paul, S.D.; Batra, D.V.; Kumar, V. 1967: Anti-microbial properties of monkey vitreous. Ophthalmo Logica 153(2): 100-106
Vichkanova, S.A.; Rubinchik, M.A. 1966: Anti-microbic properties of plectrin-diterpen from Plectranthus glauco-calyx. Farmakol Toksikol 29(5): 605-609
Maia, M.H.Dalia 1961: Anti-microbiol substances of higher plants XVIII On a colored substance, active against Mycobacterium isolated from the leaf of Barabu. J Rev Inst Antibiot: 87-92
Sahare, K.N.; Anandhraman, V.; Meshram, V.G.; Meshram, S.U.; Reddy, M.V.R.; Tumane, P.M.; Goswami, K. 2008: Anti-microfilarial activity of methanolic extract of Vitex negundo and Aegle marmelos and their phytochemical analysis. Indian Journal of Experimental Biology 46(2): 128-131
Plouguerne,E.; Hellio,C.; Deslandes,E.; Veron,B.; Stiger-Pouvreau,V. 2008: Anti-microfouling activities in extracts of two invasive algae Grateloupia turuturu and Sargassum muticum. Botanica: 3, 202-208
Lemke, M.R.; Glatzel, M.; Henneberg, A. 1995: Anti-microglia antibodies in sera of Alzheimers patients. Society for Neuroscience Abstracts 21(1-3): 2005
Kaube, H.; Goadsby, P.J. 1994: Anti-migraine compounds fail to modulate the propagation of cortical spreading depression in the cat. European Neurology 34(1): 30-35
Haida, M.; Suko, M.; Okudaira, H.; Ito, K. 1993: Anti-mite IgE, IgG, IgA, IgM antibody and the lymphocyte stimulation tests by the house dust mite antigen in patients with atopic and non-atopic asthma. Journal of Allergy and Clinical Immunology 91(1 Part 2): 174
Bruzzese, R.; Flannery, G. 1993: Anti-mitochondrial antibodies in primary biliary cirrhosis mediated antibody-dependent cellular cytotoxicity against PDH-E2 bearing targets. Journal of Leukocyte Biology 1993(Suppl ): 96
Lymberi, P.; Mappouras, D.G.; Theodoropoulou, G.; Balafas, A.; Stamatelopoulos, I.; Angelidou, C.; Terzoglou, C. 1995: Anti-mitochondrial autoantibodies in PBC constitute an heterogeneous population in terms of antibody isotype and specificity. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY Author The 9th International Congress of Immunology : 619
Snyder, R.D.; Beach, D.C.; Loudy, D.E. 1994: Anti-mitochondrial effects of bisethyl polyamines in mammalian cells. Anticancer Research 14(2a): 347-356
Ellis, J.L.; Mcloone, P.; Pedersen, K.E. 1996: Anti-mitogenic effects of the nitric oxide donor S-nitroso-N-acetylpenicillamine on human airway smooth muscle cells. FASEB Journal 10(3): A367
Friedheim, E. 1961: Anti-mitotic effects of dithiasolane compounds. Chemotherapia 2(3/4): 226-227
Deysson, G. 1965: Anti-mitotic properties of derivatives of quinazalone III Methyl-l dihydro-1-4 quinazalone-4 and N-propyl-1 dihydro-1-4 quinazalone-4. Annales Pharmaceutiques Francaises 23: 237-240
Deysson, G. 1965: Anti-mitotic properties of quinazolone derivatives I 3-Methyl-3-4-dihydro-4-quinazolone and iodomethyl derivative. Annales Pharmaceutiques Francaises 23: 163-168
HabibA.T. 1966: Anti-mold agents in bread. Alexandria J Agr Res 14(2): 133-141
Reisman, L.E.; Kashara, S.; Chung, C.Y.; Darnell, A.; Hall, B. 1966: Anti-mongolism. Studies in an infant with a partial monosomy of the 21 chromosome. Lancet 1(7434): 394-397
Dat Xuong, N.; Duchene Marullaz, M.; Vacher, J.; Buu Hoi, N.P. 1962: Anti-monoamineoxidase activity of several derivatives of nicotinyl- and isonicotinylhydrazines. Med Exptl 7(2): 85-91
Furukawa, Y.taka; Ono, Koh; Shioi, Tetsuo; Matsushima, Kouji; Matsumori, Akira 1997: Anti-monocytes chemotactic and activating factor/monocyte chemoattractant protein-1 antibody inhibits neointimal hyperplasia in rats. Circulation 96(8): I231-I232, 10-21/97
Kinoshita, M.; Iwasaki, Y.; Ikeda, K.; Shiojima, T.; Tagaya, N.; Kabayashi, T. 1998: Anti-motoneuron-disease agent. Official Gazette of the United States Patent and Trademark Office Patents 121(2): 1572
Kurihara, M.; Ishihara, K.; Hotta, K.; Tanaka, H.; Shimauchi, S. 1996: Anti-mucus glycoprotein monoclonal antibody. Official Gazette of the United States Patent and Trademark Office Patents 1192(3): 2024
van Beek, R.D.; van den Heuvel-Eibrink, M.M.; Laven, J.S.E.; de Jong, F.H.; Themmen, A.P.N.; Hakvoort-Cammel, F.G.; van den Bos, C.; van den Berg, H.; Pieters, R.; de Muinck Keizer-Schrama, S.M.P.F. 2007: Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood. Journal of Clinical Endocrinology and Metabolism 92(10): 3869-3874
Gennari, R.; Alexander, J.W.sley 1994: Anti-murine IL-6 antibody treatment improves survival in gut derived sepsis in a time-dependent manner by enhancing host defense. Surgical Forum 45: 16-18
Walcott, B.; Cameron, R.; Grine, E.; Roemer, E.; Pastor, M.; Brink, P.R. 1994: Anti-muscarinic acetylcholine receptor-like immunoreactivity in lacrimal glands. Advances in Experimental Medicine and Biology 350: 61-65
Dávila, D.F.; Donis, J.H.; Dávila, L.A.; Odreman, W.A.; de Bellabarba, G.Arata.; Villarroel, V. 2007: Anti-muscarinic autoantibodies and vagal modulation in Chagas disease: positive allosteric modulators vs desensitization and downregulation of M2 cardiac acetylcholine receptors. International Journal of Cardiology 123(3): 328-9; Author Reply 330-2
Fu, M.L.X.; Wallukat, G.; Schulze, W.; Matsui, S.; Sjogren, K.G.; Hjalmarson, A. 1997: Anti-muscarinic receptors autoantibodies from dilated cardiomyopathy induce agonist-like effects without desensitization. European Heart Journal 18(ABSTR Suppl ): 609
Fahrig, R. 1995: Anti-mutagenic agents are also co-recombinogenic and co-mutagenic agents are also anti-recombinogenic. Mutation Research 326(2): 245-246
Yamamoto, S.; Toida, I.; Watanabe, N.; Ura, T. 1994: Anti-mycobacterial activities of pyrazinamide analogues. Tubercle and Lung Disease 75(Suppl 1): 42-43
Meilak,M.; Palombo,E.A. 2008: Anti-mycobacterial activity of extracts derived from Australian medicinal plants. Research Journal Of Microbiology: 7, 535-538
Bamuamba, K.; Gammon, D.W.; Meyers, P.; Dijoux-Franca, M-Genevieve.; Scott, G. 2008: Anti-mycobacterial activity of five plant species used as traditional medicines in the Western Cape Province (South Africa). Journal of Ethnopharmacology 117(2): 385-390
Sat, N.; Murohashi, T.; Yanagisawa, K. 1960: Anti-mycobacterial activity of kanamycin derivatives in vitro and in vivo. Jour Antibiotics 13(3): 177-179
Zabucchi, G.; Borelli, V.; Banfi, E.; Tedesco, F. 1998: Anti-mycobacterial activity of leukocyte peroxidases. European Journal of Haematology 60(5): 336
Barry, C.E.IIi; Yuan, Y. 1997: Anti-mycobacterial compositions and their use for the treatment of tuberculosis and related diseases. Official Gazette of the United States Patent and Trademark Office Patents 1196(2): 1172
Grunberg, E.; Schnitzer, R.J. 1953: Anti-mycobacterial properties of a new derivative of isonlazid. Proceedings Society Exptl Biol and Med 84(1): 220-222
Morris, M.M.; Piddlesden, S.; Groome, N.; Amor, S. 1997: Anti-myelin antibodies modulate experimental allergic encephalomyelitis in Biozzi ABH mice. Biochemical Society Transactions 25(2): 168s
Morris, M.M.; Piddlesden, S.; Groome, N.; Amor, S. 1996: Anti-myelin antibodies modulated EAE in Biozzi ABH mice. Immunology 89(Suppl 1): 32
Tomassini, V.; De Giglio, L.; Reindl, M.; Russo, P.; Pestalozza, I.; Pantano, P.; Berger, T.; Pozzilli, C. 2007: Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS. Multiple Sclerosis 13(9): 1086-1094
Weidenheim, K.M.; Tricoche, M.; Rubinstein, A.; Lyman, W.D. 1994: Anti-myelin basic protein antibody in pediatric AIDS patients. Society for Neuroscience Abstracts 20(1-2): 1258
Liuzzi, G.M.; Riccio, P.; Dal Canto, M.C. 1997: Anti-myelin proteolytic activity released from microglia and macrophages after infection with Theilers murine encephalomyelitis virus Possible implication in viral demyelinating diseases. Italian Journal of Biochemistry (English Edition) 46(1): 30
Alici, E.; Konstantinidis, K.V.; Sutlu, T.; Aints, A.; Gahrton, G.ös.; Ljunggren, H.-G.; Dilber, M.S. 2007: Anti-myeloma activity of endogenous and adoptively transferred activated natural killer cells in experimental multiple myeloma model. Experimental Hematology 35(12): 1839-1846
Kuroda, J.; Kamitsuji, Y.; Kimura, S.; Ashihara, E.; Kawata, E.; Nakagawa, Y.; Takeuichi, M.; Murotani, Y.; Yokota, A.; Tanaka, R.; Andreeff, M.; Taniwaki, M.; Maekawa, T. 2008: Anti-myeloma effect of homoharringtonine with concomitant targeting of the myeloma-promoting molecules, Mcl-1, XIAP, and beta-catenin. International Journal of Hematology 87(5): 507-515
Lavergne, S.N.; Drescher, N.J.; Trepanier, L.A. 2008: Anti-myeloperoxidase and anti-cathepsin G antibodies in sulphonamide hypersensitivity. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 38(1): 199-207
Ewert, B.H.; Terrell, R.S.; Wright, C.; Jennette, J.C.; Falk, R.J. 1992: Anti-myeloperoxidase antibodies activate neutrophils using a phospholipase D-containing signal transduction pathway. Journal of the American Society of Nephrology 3(3): 585
Harper, J.M.; Lockwood, C.M.; Cooke, A. 1993: Anti-myeloperoxidase antibodies and neutrophilic vasculitis in MRL-lpr mice. Journal of Cellular Biochemistry Suppl 1993(17 Part B): 150
Dunphy, J.; Rands, A.; Mchugh, N.J. 1997: Anti-myeloperoxidase antibodies in minocycline-induced lupus syndrome. British Journal of Rheumatology 36(Suppl 1): 5
Mchugh, N.J.; Dunphy, J.; Rands, A.; Hill, C. 1996: Anti-myeloperoxidase antibodies in minocycline-induced lupus syndrome and myeloperoxidase dependent drug cytotoxicity. Arthritis and Rheumatism 39(9 Suppl): S110
Griffin, S.V.; Lockwood, C.M. 1997: Anti-myeloperoxidase antibodies interfere with the inhibition of MPO by caeruloplasmin. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 536A
Griffin, S.V.; Lockwood, C.M. 1997: Anti-myeloperoxidase antibodies interfere with the inhibition of MPO by caeruloplasmin Potential for renal injury in vasculitis. Nephrology Dialysis Transplantation 12(9): A21
Ewert, B.H.; Becker, M.; Jennette, J.C.; Falk, R.J. 1992: Anti-myeloperoxidase antibodies stimulate neutrophils to adhere to cultured human endothelial cells utilizing the beta-2-integrin CD11/18. Journal of the American Society of Nephrology 3(3): 585
Sekiyama, N.; Akahoshi, T.; Kondo, H. 1994: Anti-myeloperoxidase antibody induces neutrophil apoptosis through the production of oxygen radicals. Arthritis and Rheumatism 37(9 Suppl): S267
Howe, S.; Eaker, W.Y.; Sallustio, J.E.; Williams, R.C.Jr 1993: Anti-myenteric neuronal antibodies in patients with scleroderma and related diseases. Clinical Research 41(2): 246A
Menaker, M.E.; Aicher, S.A.; Welsh, J.P. 1996: Anti-myoclonic effect of ablation of the inferior olive. FASEB Journal 10(3): A562
Limas, C.J.; Limas, C.; Boudoulas, H.; Goldenberg, I.F.; Sparks, L.; Wooley, C.F.; Graber, H. 1994: Anti-myosin antibodies in familial dilated cardiomyopathy. European Heart Journal 15(ABSTR Suppl ): 24
Sikorska, H.; Savoie, S.; Desputeau, C. 1997: Anti-myosin mouse monoclonal antibody and method of use for diagnosis of myocardial infarction. Official Gazette of the United States Patent and Trademark Office Patents 1198(1): 328
James, J.A.; Harley, J.B. 1993: Anti-nRNP A autoantibodies bind constituent nRNP A peptides in two patterns and bind a neighboring set of surface structures. Clinical Research 41(2): 246A
Richards, H.B.; Satoh, M.; Okano, T.; Reeves, W.H. 1996: Anti-nRNP/Sm and Su autoantibodies in pristane-treated mice are T cell dependent and independent of polyclonal activation. Arthritis and Rheumatism 39(9 Suppl): S179
Mushiroi, T.; Shibahara, R.; Itoh, Y.; Ukai, Y.; Yoshikuni, Y.; Kimura, K. 1995: Anti-narcotic effect of a TRH analog, NS-3 , is mediated by catecholaminergic and cholinergic mechanisms. Japanese Journal of Pharmacology 67(Suppl 1): 151P
Audrain, M.A.P.; Baranger, T.A.R.; Devys, A.; Moguilevski, N.; Lockwood, C.M.; Muller, J.Y.; Esnault, V.L.M. 1996: Anti-native and recombinant myeloperoxidase monoclonals and human auto-antibodies. Journal of the American Society of Nephrology 7(9): 1769
Pereira, L.; Cunha, M. 1962: Anti-neoplas-tic intralymphatic chemotherapy. Angiologia 14(5): 235-238
Vardanyan, S.A. 1964: Anti-neoplastic activity of O- -D,L-tyrosine. Vop Onkol 10(6): 90-94
Trusheikina, V.I. 1964: Anti-neoplastic activity of o-di- amino-dl-phenylalanine. Vop Onkol 10(9): 82-84
Chernov, V.A.; Volodarskaia, S.M.; Lytkina, L.G. 1964: Antineoplastic Activity of some Amines and Amino Acids of the Indole Series. Voprosy Onkologii 10: 76-81
Bergeron, R.J. 1996: Anti-neoplastic anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment. Official Gazette of the United States Patent and Trademark Office Patents 1188(5): 3720-3721
Moheno, P.B.B. 1996: Anti-neoplastic compositions and methods for application thereof. Official Gazette of the United States Patent and Trademark Office Patents 1188(2): 1261
Ostrovskaya, L.A.; Kruglyak, S.A.; Vermel', E.M. 1966: Anti-neoplastic effect of some nitrosourea derivatives. Vop Onkol 12(10): 83-87
Liu, Y.; Loudon, W.G.; Prahbu, S.S.; Fillmore, H.F.; Westin, E.H.; Broaddus, W.C. 1996: Anti-neoplastic effects of BCNU on a RT2 glioma animal model by positive pressure intratumoral infusion. Proceedings of the American Association for Cancer Research 37: 380
Bergeron, R.J. 1996: Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and method of treatment. Official Gazette of the United States Patent and Trademark Office Patents 1184(1): 414
Gregson, N.A.; Hall, S.; Hughes, R.A.C. 1992: Anti-nerve antibodies in chronic idiopathic demyelinating poly-radiculoneuropathy. Journal of Neurology Neurosurgery and Psychiatry 55(12): 1214-1215
Saban, R.; Haak Frendscho, M.; Mentone Saban, D.R.; Bjorling, D.E. 1996: Anti-nerve growth factor monoclonal antibody increases lipopolysaccharide -induced transforming growth factor-beta 1 release from mouse urinary bladder. FASEB Journal 10(3): A167
Deubzer, H.E.; Ehemann, V.; Kulozik, A.E.; Westermann, F.; Savelyeva, L.; Kopp-Schneider, A.; Riester, D.; Schwab, M.; Witt, O. 2008: Anti-neuroblastoma activity of Helminthosporium carbonum (HC)-toxin is superior to that of other differentiating compounds in vitro. Cancer Letters 264(1): 21-28
Folpe, A.L.; Patterson, K.; Gown, A.M. 1997: Anti-neuroblastoma antibody NB-84 also identifies a subset of other small blue round cell tumors. Laboratory Investigation 76(1): 157A
Beteschart, C.; Zimmermann, K. 1998: Anti-neurodegeneratively active 10-aminoaliphathyl-dibenzi oxepines. Official Gazette of the United States Patent and Trademark Office Patents 1212(2): 1847
Michaelson, D.M.; Gordon, I.; Dubovik, V.; Rehavi, M. 1993: Anti-neuronal antibodies as agents of neuropathology in Alzheimers disease. Journal of Neurochemistry 61(Suppl ): S7
Hallett, J.J.; Laurino, J.P.; Kiessling, L.S. 1994: Anti-neuronal antibodies reactivity with neuroblastoma membrane proteins in children with TICS. Pediatric Research 37(4 Part 2): 380A
Moll, J.W.B.; Markusse, H.M.; Henzen Logmans, S.C.; Vecht, C.J. 1993: Anti-neuronal specific antibodies in Sjogrens syndrome. Neurology 43(4 Suppl 2): A419
Forde, A.M.; Feighery, C.; O'connor, C.; Jackson, J. 1994: Anti-neutrophil and anti-monocyte cytoplasmic antibodies. Arthritis and Rheumatism 37(9 Suppl): S426
Shandelya, S.M.; Lefer, D.J.; Zweier, J.L. 1992: Anti-neutrophil and cardioprotective actions of apolipoprotein A-1 in the ischemic-reperfused rat heart. Circulation 86(4 Suppl 1): I80
Braun, M.G.; Csernok, E.; Schmitt, W.; Hauschild, S.; Gross, W.L. 1993: Anti-neutrophil antibodies and extraarticular involvement in rheumatoid arthritis. Clinical and Experimental Immunology 93(Suppl 1): 33
Klumpp, T.R.; Herman, J.H.; Mangan, K.F.; Goldberg, S.L.; Macdonald, J.S. 1993: Anti-neutrophil antibodies and unexpected neutropenia following bone marrow transplantation. Blood 82(10 Suppl 1): 583A
Mallolas, J.; Esteve, M.; Rius, E.; Cabre, E.; Gassull, M.A. 1998: Anti-neutrophil antibodies associated to ulcerative colitis interact with a nuclear antigen during the process of apoptosis. Gastroenterology 114(4 Part 2): A1031
Castro Mussot, M.E.; Bautista Maldonado, B.; Faure, A.; Garcia Gonzalez, J.E. 1995: Anti-neutrophil antibodies in juvenile systemic lupus erythematosus. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY Author The 9th International Congress of Immunology : 622
Braun, M.G.; Csernok, E.; Schmitt, W.H.; Hauschild, S.; Gross, W.L. 1993: Anti-neutrophil antibodies in rheumatoid arthritis and Felty syndrome Extra-articular involvement and clinical course. Arthritis and Rheumatism 36(9 Suppl): S125
Hartman, K.R.; Atolagbe, T.A. 1993: Anti-neutrophil antibodies of the IG-M class in autoimmune neutropenia. Clinical Research 41(2): 164A
Miyamoto, M.; Shibata, Y. 1998: Anti-neutrophil antibody in autoimmune neutropenia Report of a case. Vox Sanguinis 74(Suppl 1): 1400
Laux-End, R.; Gerber, H.A.; Sauvain, M.J.; Bianchetti, M.G. 1997: Anti-neutrophil autoantibodies and systemic vasculitis: a report of five cases. Acta Paediatrica 86(4): 438-439
Testa, A.; Audrain, M.; Baranger, T.; Sesboue, R.; Martin, J.P.; Esnault, V.L.M. 1993: Anti-neutrophil cytoplasm antibodies and alpha-1-antitrypsin phenotype. Clinical and Experimental Immunology 93(Suppl 1): 16
Goldenstein Schainberg, C.; Radu, A.S.; Yoshinari, N.H.; Pereira, R.M.; Cossermelli, W. 1992: Anti-neutrophil cytoplasm antibodies in Brazilian patients with juvenile rheumatoid arthritis. Arthritis and Rheumatism 35(9 Suppl): S327
Harper, J.M.; Lockwood, C.M.; Cooke, A. 1993: Anti-neutrophil cytoplasm antibodies in MRL-LPR/LPR mice. Clinical and Experimental Immunology 93(Suppl 1): 22
Meyer, O.; De Bandt, M.; Haim, T.; Kahn, M.F. 1992: Anti-neutrophil cytoplasm antibodies in giant cell arteritis and polymyalgia rheumatica. Annales de Medecine Interne 143(7): 476
Berthelot, J.M.; Lamour, A.; Mottier, D.; Pennec, Y.L.; Dueymes, M.; Jouquan, J.; Le Goff, P.; Youinou, P. 1992: Anti-neutrophil cytoplasm antibodies in patients with giant cell arteritis and/or polymyalgia rheumatica. Annales de Medecine Interne 143(7): 429-432
Brooks, C.J.; Adu, D.; Savage, C.O.S. 1995: Anti-neutrophil cytoplasm antibodies stimulate neutrophils to secrete cytokine IL-1-beta. Journal of the American Society of Nephrology 6(3): 823
Baranger, T.A.R.; Audrain, M.A.P.; Martin, S.J.; Sesboue, R.; Martin, J.P.; Esnault, V.L.M. 1996: Anti-neutrophil cytoplasm antibody in unselected alpha-1-antitrypsin deficient patients. Nephrology Dialysis Transplantation 11(6): A22
Finnern, R.; Lockwood, M.; Ouwehand, W. 1993: Anti-neutrophil cytoplasm autoantibody fragments from a human V-gene library. Clinical and Experimental Immunology 93(Suppl 1): 21
Ortiz, A.M.; Laffon, A.; Gonzalez Alvaro, I. 1997: Anti-neutrophil cytoplasmatic antibodies Current situation. Revista Espanola de Reumatologia 24(4): 122-127
Lionaki, S.; Jennette, J.C.; Falk, R.J. 2007: Anti-neutrophil cytoplasmic (ANCA) and anti-glomerular basement membrane (GBM) autoantibodies in necrotizing and crescentic glomerulonephritis. Seminars in Immunopathology 29(4): 459-474
Stegeman, C.A.; Tervaert, J.W.; Kallenberg, C.G. 1994: Anti-neutrophil cytoplasmic antibodies: tools for diagnosis and follow-up in systemic vasculitis. Annales de Medecine Interne 145(8): 523-532
Hauschild, S.; Schmitt, W.H.; Csernok, E.; Flesch, B.K.; Rautmann, A.; Gross, W.L. 1992: Anti-neutrophil cytoplasmic antibodies and their target antigens A diagnostic guideline for vasculitic disorders. Arthritis and Rheumatism 35(9 Suppl): S52
Ahmed, A.E.E.; Agopian, M.S. 1995: Anti-neutrophil cytoplasmic antibodies are important for diagnosis of vasculitis. Arthritis and Rheumatism 38(9 Suppl): S208
Schmitt, W.H.; Csernok, E.; Hauschild, S.; Rautmann, A.; Gross, W.L. 1992: Anti-neutrophil cytoplasmic antibodies directed against lysozyme A new type of autoantibodies. Arthritis and Rheumatism 35(9 Suppl): S115
Porges, A.J.; Redecha, P.B.; Kimberly, R.P. 1992: Anti-neutrophil cytoplasmic antibodies engage neutrophil Fc-gamma-receptor II. Arthritis and Rheumatism 35(9 Suppl): S115
Kinjoh, K.K.; Jennette, J.C.; Falk, R.J.; Good, R.A. 1995: Anti-neutrophil cytoplasmic antibodies in SCG/Kj mice. Modern Pathology 8(1): 159
Bakkaloglu, A.; Saatci, U.; Ozen, S.; Besbas, N.; Ozdemir, S.; Topaloglu, R.; Kocak, H. 1996: Anti-neutrophil cytoplasmic antibodies in childhood glomerular and vasculitic diseases. Pediatric Nephrology 10(4): C126
Bakkaloglu, A.; Ozen, S.; Saatci, U.; Besbas, N.; Guven, A.G.; Kocak, H.; Topaloglu, R.; Tinaztepe, K. 1997: Anti-neutrophil cytoplasmic antibodies in childhood polyarteritis nodosa. Pediatric Nephrology 11(5): C41
Wong, S.N.; Shah, V.; Dillon, M.J. 1992: Anti-neutrophil cytoplasmic antibodies in childhood systemic vasculitis. Journal of the American Society of Nephrology 3(3): 668
Ng, T.M.; Fock, K.M.; Chew, C.N.; Chng, H.H.; Teo, D. 1993: Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease and tuberculous colitis. Singapore Medical Journal 34(1): 89
Mulder, A.H.L.; Van Rossum, M.A.J.; Horst, G.; Limburg, P.C.; De Graeff Meeder, E.R.; Kuis, W.; Kallenberg, C.G.M. 1994: Anti-neutrophil cytoplasmic antibodies in juvenile chronic arthritis. Arthritis and Rheumatism 37(9 Suppl): S400
Chin, H.J.; Lim, C.S.; Ahn, C.; Park, I.S.; Han, J.S.; Kim, S.; Lee, J.S. 1995: Anti-neutrophil cytoplasmic antibodies in lupus nephritis. Journal of the American Society of Nephrology 6(3): 919
Roozendaal, C.; Van Milligen, D.W.t, A.W.M.; Haagsma, E.B.; Horst, G.; Schwarze, C.; Peter, H.H.; Kleibeuker, J.H.; Tervaert, J.W.C.hen; Limburg, P.C.; Kallenberg, C.G.M. 1998: Anti-neutrophil cytoplasmic antibodies in primary sclerosing cholangitis Target antigens and clinical associations. Gastroenterology 114(4 Part 2): A1329
Locht, H.; Peen, E.; Skogh, T. 1998: Anti-neutrophil cytoplasmic antibodies in reactive arthritis and ankylosing spondylitis. Clinical and Experimental Immunology 112(Suppl 1): 51
Orth, T.; Schwarting, A.; Gerken, G.; Meyer Zum Bueschenfelde, K.H.; Mayet, W.J. 1994: Anti-neutrophil cytoplasmic antibodies in ulcerative colitis, primary sclerosing cholangitis and autoimmune hepatitis. Immunobiology 191(2-3): 164-165
Casselman, B.; Miller, B.F.; Kilgore, K.S.; Warren, J.S. 1995: Anti-neutrophil cytoplasmic antibodies induce MCP-1 release from human monocytes. FASEB Journal 9(3): A345
Kocher, M.; Kimberly, R.P.; Edberg, J.C. 1997: Anti-neutrophil cytoplasmic antibodies induce adhesion receptor changes on neutrophils. Arthritis and Rheumatism 40(9 Suppl): S68
Harper, L.; Radford, D.J.; Adu, D. 1998: Anti-neutrophil cytoplasmic antibodies induce neutrophil apoptosis in primed neutrophils II vitro. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 439A
Edberg, J.C.; Kocher, M.; Fleit, H.; Kimberly, R.P. 1998: Anti-neutrophil cytoplasmic antibodies preferentially engage FcgammaRII1b on neutrophils. Arthritis and Rheumatism 41(9 Suppl): S243
Mizoguchi, E.; Mizoguchi, A.; Chiba, C.; Niles, J.L.; Bhan, A.K. 1997: Anti-neutrophil cytoplasmic antibodies producing B cells in TCR-alpha-mutant mice with inflammatory bowel disease. Gastroenterology 112(4 Suppl): A1044
Harper, L.; Radford, D.J.; Adu, D.; Savage, C.O.S. 1998: Anti-neutrophil cytoplasmic antibodies prolong neutrophil survival in vitro by inhibiting apoptosis. Clinical and Experimental Immunology 112(Suppl 1): 46
Harper, L.; Radford, D.J.; Adu, D.; Savage, C.O.S. 1998: Anti-neutrophil cytoplasmic antibodies prolongs neutrophil survival in vitro by inhibiting apoptosis. Nephrology Dialysis Transplantation 13(6): A21
Novo, R.; Noel, L.H.; Gubler, M.C.; Prieur, A.M.; Hayem, F.; Niaudet, P. 1996: Anti-neutrophil cytoplasmic antibody associated glomerulonephritis with IN children. Pediatric Nephrology 10(4): C149
Kocher, M.; Edberg, J.; Fleit, H.; Kimberly, R. 1996: Anti-neutrophil cytoplasmic antibody engagement of Fc-gamma-RIIIb on neutrophils is blocked by soluble Fc-gamma receptor. Arthritis and Rheumatism 39(9 Suppl): S210
Ito, Y.; Nishi, A.; Sakaguchi, M.; Suzuki, Y.; Kaneko, K.; Yasuoka, C.; Tomita, S.; Kato, H. 1995: Anti-neutrophil cytoplasmic antibody for proteinase 3 in a child with polyarteritis nodosa. Acta Paediatrica Japonica: Overseas Edition 37(1): 116-119
Macedo, G.; Carvalho, L.; Bodas, A.; Vale, A.M.H.; Sarmento, J.A.; Ribeiro, T. 1995: Anti-neutrophil cytoplasmic antibody in chronic liver disease. Gastroenterology 108(4 Suppl): A1114
Navarro, J.F.; Quereda, C.; Rivera, M.; Navarro, F.J.; Ortuño, J. 1994: Anti-neutrophil cytoplasmic antibody-associated paraneoplastic vasculitis. Postgraduate Medical Journal 70(823): 373-375
Walker, B.A.M.; Smith, T.; Kim, S.S.W.; Johnston, G. 1994: Anti-neutrophil cytoplasmic antibody-associated vasculitis in a xenogeneic model. FASEB Journal 8(4-5): A320
Frasca, G.M.; Vangelista, A.; Feletti, C.; Di Luca, M.; Lucia, Neri; Loris, Neri; Borgnino, L.C.; Giudicissi, A.; Bonomini, V. 1993: Anti-neutrophil cytoplasmic autoantibodies and disease activity in systemic vasculitis A prospective study in 57 patients. Kidney International 43(3): 759
Mitarai, T. 1998: Anti-neutrophil cytoplasmic autoantibodies associated renal diseases and thrombotic microangiopathy. Internal Medicine 37(2): 207-210
Ben Smith, A.; Radford, D.J.; Martin, A.; Wakelam, M.J.O.; Savage, C.O.S. 1998: Anti-neutrophil cytoplasmic autoantibodies engage FcgammaR and activate neutrophils via a PI 3-kinase, but not phospholipase D, dependent pathway. Immunology 95(Suppl 1): 73
Jennette, J.C.; Tuttle, R.H.; Wilkman, A.S.; Snowden, M.B.; Falk, R.J. 1993: Anti-neutrophil cytoplasmic autoantibodies in patients with pauci-immune necrotizing and crescentic glomerulonephritis. Clinical and Experimental Immunology 93(Suppl 1): 44
Kettritz, R.; Jennette, J.C.; Falk, R.J. 1995: Anti-neutrophil cytoplasmic autoantibodies trigger superoxide release of human neutrophils by cross-linking their target antigens. Journal of the American Society of Nephrology 6(3): 835
Finnern, R.; Marks, J.D.; Bye, J.M.; Lockwood, C.M.; Ouwehand, W.H. 1993: Anti-neutrophil cytoplasmic autoantibody fragments from human V-gene libraries. Blood 82(10 Suppl 1): 30A
Bosch, X.; Font, J.; Llena, J.; Collado, A.; Mirapeix, E.; Urbano Marquez, A.; Ingelmo, M. 1992: Anti-neutrophil perinuclear antibodies but not anti-neutrophil cytoplasmic antibodies in rheumatoid arthritis. Arthritis and Rheumatism 35(9 Suppl): S144
Ossi, E.; Boin, F.; Conte, E.; Bonaguro, R.; Siviero, M.; Punzi, D. 1998: Anti-neutrophils cytoplasm autoantibodies in biological fluids. Clinical and Experimental Immunology 112(Suppl 1): 24
Hazard, R.; Corteggiani, E.; Cornec, A. 1949: Anti-nicotinic action of several esters of diethylaminoethanol. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 143(9-10): 605-606
Chu, C.; Huang, Y.; Chen, Y-Feng.; Wu, J-Hong.; Rahman, K.; Zheng, H-Chen.; Qin, L-Ping. 2008: Anti-nociceptive activity of aqueous fraction from the MeOH extracts of Paederia scandens in mice. Journal of Ethnopharmacology 118(1): 177-180
Kang, O.-H.; Chae, H.-S.; Oh, Y.-C.; Choi, J.-G.; Lee, Y.-S.; Jang, H.-J.; Kim, J.-H.; Kim, Y.C.; Sohn, D.H.; Park, H.; Kwon, D.-Y. 2008: Anti-nociceptive and anti-inflammatory effects of Angelicae dahuricae radix through inhibition of the expression of inducible nitric oxide synthase and NO production. American Journal of Chinese Medicine 36(5): 913-928
Hummel, T.; Loetsch, J.; Kraetsch, H.G.; Kobal, G. 1994: Anti-nociceptive and anti-inflammatory effects of ibuprofen. Naunyn-Schmiedeberg's Archives of Pharmacology 349(Suppl): R138
Onasanwo,S.A.; Pal,A.; George,B.; Olaleye,S.B. 2008: Anti-nociceptive and anti-inflammatory potencies of the hydro-ethanol extract and fractions from Hedranthera barteri leaf. African Journal Of Biomedical Research: 3, 311-321
Liu, T.; Pang, X-Yan.; Jiang, F.; Bai, Z-Tao.; Ji, Y-Hua. 2008: Anti-nociceptive effects induced by intrathecal injection of BmK AS, a polypeptide from the venom of Chinese-scorpion Buthus martensi Karsch, in rat formalin test. Journal of Ethnopharmacology 117(2): 332-338
Cramer, C.L.; Knowles, M.A.; Hudzik, T.J.; Ray, R.K.; Murray, R.J.; Balestra, M.; Matz, J.R.; Palmer, G.C. 1995: Anti-nociceptive properties of uncompetitive NMDA receptor antagonists. FASEB Journal 9(3): A373
Chan, E.Y.T.; Lie, A.K.W.; Chiu, E.K.W.; Chan, T.K. 1995: Anti-nuclear and anti-cytoplasmic autoantibodies after allogeneic bone marrow transplantation. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY Author The 9th International Congress of Immunology : 433
Terada, S.; Morshed, S.A.; Nishioka, M. 1994: Anti-nuclear antibodies in autoimmune hepatitis. Nishioka, M, Toda, G, Zeniya, M Autoimmune hepatitis 177-184
Kleiner, J.A.; Lasley, M.V.; Fisher, R.H. 1995: Anti-nuclear antibodies in fibromyalgia patients presenting to a general allergy clinic. Journal of Allergy and Clinical Immunology 95(1 Part 2): 148
Castanedo, J.P.; White, J.G.; Williams, R.C. 1967: Anti-nuclear antibodies in normal human subjects. Arthritis and Rheumatism 10(5): 431-443
Wenisch, C.; Graninger, W.; Looareesuwan, S.; Hoefler, H.; Steiner, G. 1995: Anti-nuclear autoantibodies in Plasmodium falciparum infection preferentially recognize a 60 kD nuclear antigen. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY Author The 9th International Congress of Immunology : 809
Iakoubov, L.; Rokhlin, O.; Torchilin, V. 1995: Anti-nuclear autoantibodies of the aged reactive against the surface of tumor but not normal cells. Immunology Letters 47(1-2): 147-149
Bickerstaff, M.C.M.; Botto, M.; Cook, T.; Mitchell, D.; Tennent, G.A.; Walport, M.J.; Pepys, M.B. 1998: Anti-nuclear autoimmunity in mice with targeted deletion of serum amyloid P component. Arthritis and Rheumatism 41(9 Suppl): S175
Holborow, J.; Johnson, G.D. 1964: Antinuclear Factor in Systemic Lupus Erythematosus. A Consideration of the Immunofluorescent Method of Detecting Antinuclear Antibodies, with Results Obtained in a Family Study. Arthritis and Rheumatism 7: 119-127
Kornreich, H.K.; Drexler, E.; Hanson, V. 1966: Antinulear factors in childhood rheumatic diseases. Journal of Pediatrics 69(6): 1039-1045
Barnett, E.V.; North, A.F.; Condemi, J.J.; Jacox, R.F.; Vaughan, J.H. 1965: Antinuclear Factors in Systemic Lupus Erythematosus and Rheumatoid Arthritis. Annals of Internal Medicine 63: 100-108
Schwartz, D.W.M.; Zakovsky, B.; Fohringer, S.; Mayr, W.R. 1998: Anti-nuclear-antibodies in blood donors with positive direct anti-human-globulin tests. Vox Sanguinis 74(Suppl 1): 1463
Faber, V.; Elling, P. 1965: Anti-nuclear-factors as determined by the immuno-fluorescent-antibody technique. Acta Med Scand 177(3): 309-319
Beck, J.S.; Anderson, J.R.; McELHINNEY, A.J.; Rowell, N.R. 1962: Antinucleolar antibodies. Lancet 2(7256): 575-577
Tupchong, M.A.; Wither, J.; Hallett, D.; Gladman, D.D. 1997: Anti-nucleosome antibodies as markers for renal disease in lupus nephritis. Arthritis and Rheumatism 40(9 Suppl): S304
Chabre, H.; Amoura, Z.; Lotton, C.; Bach, J.F.; Jacob, L. 1993: Anti-nucleosome antibodies autoimmune response precedes the production of anti-dsDNA and anti-histone antibodies in MRL MP +/+ and LPR/LPR mice. Arthritis and Rheumatism 36(9 Suppl): S243
Kramers, K.; Van Bruggen, M.; Assmann, K.; Dijkman, H.; Hylkema, M.; Smeenk, R.; Berden, J. 1993: Anti-nucleosome antibodies complexed to histones become Farr positive and these complexes are able to bind to the glomerular basement membrane. Journal of the American Society of Nephrology 4(3): 612
Massa, M.; De Benedetti, F.; Pignatti, P.; Migliori, C.; Ruperto, N.; Monestier, M.; Martini, A. 1992: Anti-nucleosome reactivity in patients with systemic lupus erythematosus. Arthritis and Rheumatism 35(9 Suppl): S228
Mailer,R.J.; McFadden,A.; Ayton,J.; Redden,B. 2008: Anti-nutritional components, fibre, sinapine and glucosinolate content, in Australian canola meal. Journal Of The American Oil Chemists' Society: 10, 937-944
Ekop,A.S.; Obot,I.B.; Ikpatt,E.N. 2008: Anti-nutritional factors and potassium bromate content in bread and flour samples in Uyo Metropolis, Nigeria. E Journal Of Chemistry: 4, 736-741
Jansman, A.J.M.; Van Der Poel, A.F.B. 1993: Anti-nutritional factors in legumes seeds nutritional effects and -technological inactivation. Mededelingen van de Faculteit Landbouwwetenschappen - Rijksuniversiteit Gent 58(4A): 1657-1668
Matsubara, T.; Ueno, M.; Saito, H. 1996: Anti-obese action of Byakujutsu and a prolongation of the life span in SHRSP. Japanese Journal of Pharmacology 71(Suppl 1): 326P
Suzuki, K. 1997: Anti-obesity agent 4-cholesten-3-one. Official Gazette of the United States Patent and Trademark Office Patents 1196(2): 1154
Suzuki, K.; Nakata, T.; Shimizu, T.; Enomoto, K. 1998: Anti-obesity agents. Official Gazette of the United States Patent and Trademark Office Patents 1206(3): 2183
Sandoval, C.M.; Salzameda, B.; Reyes, K.; Williams, T.; Hohman, V.S.; Plesniak, L.A. 2007: Anti-obesity and anti-tumor pro-apoptotic peptides are sufficient to cause release of cytochrome c from vesicles. Febs Letters 581(28): 5464-5468
WooMyoungNam; BokSongHae; LeeMiKyung; KimHyeJin; JeonSeonMin; DoGyeongMin; ShinSuKyung; HaTaeYeul; ChoiMyungSook 2008: Anti-obesity and hypolipidemic effects of a proprietary herb and fiber combination in rats fed high-fat diets. Journal Of Medicinal Food: 1, 169-178
Adan, R.A.H.; Vanderschuren, L.J.M.J.; la Fleur, S.E. 2008: Anti-obesity drugs and neural circuits of feeding. Trends in Pharmacological Sciences 29(4): 208-217
Sakane, N.; Yoshida, T.; Umekawa, T.; Kondo, M. 1994: Anti-obesity effect of Bofu-tsusho-san, a traditional Japanese herbal medicine, in monosodium-L-glutamate obese mice. International Journal of Obesity 18(Suppl 2): 131
Suzuki, K.; Enomoto, K.; Niki, R. 1994: Anti-obesity effect of cholest-4-en-3-one, an intestinal catabolite of cholesterol. International Journal of Obesity 18(Suppl 2): 80
Hainault, I.; Carlotti, M.; Hajduch, E.; Guichard, C.; Lavau, M. 1994: Anti-obesity effect of dietary fish oil Studies in high fat diet and in genetically induced obesities. International Journal of Obesity 18(Suppl 2): 137
Loh, M.Y.; Flatt, W.P.; Martin, R.J.; Hausman, D.B. 1996: Anti-obesity effect of palm-olein in high fat diets. FASEB Journal 10(3): A219
Kim, S-Jin.; Jung, J.Young.; Kim, H.Won.; Park, T. 2008: Anti-obesity effects of Juniperus chinensis extract are associated with increased AMP-activated protein kinase expression and phosphorylation in the visceral adipose tissue of rats. Biological and Pharmaceutical Bulletin 31(7): 1415-1421
Li, J.-J.; Huang, C.J.; Xie, D. 2008: Anti-obesity effects of conjugated linoleic acid, docosahexaenoic acid, and eicosapentaenoic acid. Molecular Nutrition and Food Research 52(6): 631-645
Scislowski, P.W.D.; Prevelige, R.; Cincotta, A.H. 1998: Anti-obesity effects of dopamine agonist treatment are coupled with increased endogenous production of dehydroepiandrosterone sulfate on on/ob mice. International Journal of Obesity 22(Suppl 3): S73
Hu, J-Ning.; Zhu, X-Mei.; Han, L-Kun.; Saito, M.; Sun, Y-Shi.; Yoshikawa, M.; Kimura, Y.; Zheng, Y-Nan. 2008: Anti-obesity effects of escins extracted from the seeds of Aesculus turbinata BLUME (Hippocastanaceae). Chemical and Pharmaceutical Bulletin 56(1): 12-16
Nishi, S.; Saito, Y.; Koaze, H.; Hironaka, K.; Kojima, M. 2007: Anti-obesity effects of seaberry Hippophae rhamnoides leaf polyphenols SBLPP in male mice fed a high-fat diet. Nippon Shokuhin Kagaku Kogaku Kaishi 54(11): 477-481
Dimarchi, R.D.; Flora, D.B.; Heath, W.F.Jr; Hoffmann, J.A.; Shields, J.E.; Smiley, D.L. 1996: Anti-obesity proteins. Official Gazette of the United States Patent and Trademark Office Patents 1187(2): 1260
Ishibashi, T.; Kezuka, H.; Yoshino, S.; Shimizu, N.; Tsuda, M.; Imazeki, S. 1995: Anti-octopus rhodopsin monoclonal antibody. Official Gazette of the United States Patent and Trademark Office Patents 1174(2): 1178
Gabor, M.; Razga, Z. 1992: Anti-oedematous effects of the H-1-receptor antagonist dimethindene maleate. Agents and Actions 1992(SPEC CONF ISSUE): C444-C447
Cook, H.; Kitts, W.D. 1964: Anti-Oestrogenic Activity in Yellow Pine Needles (Pinus Ponderosa). Acta Endocrinologica 45: 33-39
Emmens, G.W.; Collins, D.J.; Hobbs, J.J.; Miller, B.G.; Owen, W.H. 1968: Anti-oestrogenic and antifertility properties of some 4,4'-dihydroxybibenzyls. Journal of Reproduction and Fertility 16(1): 1-6
Nannenga, B.L.; Zameer, A.; Sierks, M.R. 2008: Anti-oligomeric single chain variable domain antibody differentially affects huntingtin and alpha-synuclein aggregates. Febs Letters 582(4): 517-522
Irie, A.; Kijima, H.; Ohkawa, T.; Bouffard, D.Y.; Suzuki, T.; Curcio, L.D.; Holm, P.S.; Sassani, A.; Scanlon, K.J. 1997: Anti-oncogene ribozymes for cancer gene therapy. Advances in Pharmacology 40: 207-257
Calabretta, B.; Skorski, T.; Zon, G. 1994: Anti-oncogene targeted therapy of leukemic SCID mice. AIDS Research and Human Retroviruses 10(Suppl 3): S80
Packard, B.; Komoriya, A. 1997: Anti-oncoimmunin-M antibodies and uses thereof. Official Gazette of the United States Patent and Trademark Office Patents 1199(1): 381
Radka, S.F.; Linsley, P.S.; Shoyab, M. 1997: Anti-oncostatin M monoclonal antibodies. Official Gazette of the United States Patent and Trademark Office Patents 1203(4): 3027
Pasternak, G.W. 1994: Anti-opioid activity of sigma-1 systems. Regulatory Peptides 54(1): 219-220
Gelot, A.; Francés, B.; Roussin, A.; Latapie, J.P.; Zajac, J.M. 1998: Anti-opioid efficacy of neuropeptide FF in morphine-tolerant mice. Brain Research 808(2): 166-173
Weiss, E.; Ofek, I.; Kashman, Y.; Goldhar, J.; Sharon, N. 1998: Anti-oral-microbial adhesion fraction derived from vaccinium. Official Gazette of the United States Patent and Trademark Office Patents 121(4): 3910
L.Jing 1995: Anti-order magmatic evolution and genetic discussion of the Yuhezhai Complex rock body in Eshan, Yunnan. Yunnan Dizhi = Yunnan Geology 14(3): 231-237
Ulrich, D.; Huguenard, J.R. 1995: Anti-oscillatory effects of adenosine in the thalamus. Society for Neuroscience Abstracts 21(1-3): 1017
Takasu, H. 2008: Anti-osteoclastogenic action of active vitamin D. Nutrition Reviews 66(10 Suppl 2: S113-S115
Shudo, K.; Sugioka, T.; Inazu, M.; Tanaka, H.; Inoue, T.; Kitamura, K. 1997: Anti-osteopathic composition. Official Gazette of the United States Patent and Trademark Office Patents 1205(5): 3925
D.S.lva Jardine, P.; Thompson, D. 1996: Anti-osteoporosis agents. Bristol, J A Annual Reports in Medicinal Chemistry: 211-220
Rajendran, K.G.; Sood, A.; Spielvogel, B.F.; Hall, I.H.; Norwoodi, V.M.I.; Morse, K.W. 1995: Anti-osteoporotic activity of metal complexes of amine carboxyboranes. Applied Organometallic Chemistry 9(2): 111-119
Chatterjee, S.; Maitra, T.K.; Chakravarty, B. 1996: Anti-ovarian antibodies in premature ovarian failure. Journal of Endocrinology 148(Suppl ): P39
Rivkin, E.; Kohen, M.; Lahita, R.G. 1992: Anti-ovarian antibody in SLE. Arthritis and Rheumatism 35(9 Suppl): S298
Barbarino Monnier, P.; Gobert, B.; Bene, M.C.; Faure, G.C. 1997: Anti-ovarian auto-immunity, immunosuppression and in vitro fertilization. Journal of Reproductive Immunology 34(1): 100
Kincl, F.A.; Dorfman, R.I. 1963: Anti-ovulatory activity of steroids administered by gavage in the adult oestrus rabbit. ACTA ENDOCRINOL 42(Suppl 72): 17-30
Kincl, F.A.; Ralph, I.Dorfman 1963: Anti-ovulatory activity of subcutaneously injected steroids in the adult oestrus rabbit. ACTA ENDOCRINOL 42(Suppl 72): 3-15
Le Bars, S. 1965: Anti-ovulatory and anti-gonadotropic activities of chlormadinone in rabbit and in rat. C R Seances Society Biol parts 159(12): 2479-2483
Plummer, J.M. 1963: Anti-ovulatory and other biological properties of megestrol acetate 17 -acetoxy-6-methyl-pregna 46-diene-320-dione. Jour Reproduct And Fert: 331-346
Greenwald, G.S. 1965: Anti-ovulatory potency of various steroids, determined by single injection into female hamsters. Journal of Endocrinology 33(1): 25-32
Sanches, L.B.; da Silva, I.T.; Paz, A.F.S.; Fisberg, M.; Cintra, I.P.; Villar, B.S.; Damasceno, Nágila.R.T. 2008: Anti-oxLDL autoantibodies and their correlation with lipid profile and nutritional status in adolescents. Jornal de Pediatria 84(3): 258-263
Platt, J.T.; Pugliese, P.T.; Pawelek, J.M. 1996: Anti-oxidant activity and protection from UV radiation by synthetic melanins. Pigment Cell Research 1996(Suppl 5): 73
Dhote, V.; Balaraman, R. 2008: Anti-oxidant activity mediated neuroprotective potential of trimetazidine on focal cerebral ischaemia-reperfusion injury in rats. Clinical and Experimental Pharmacology and Physiology 35(5-6): 630-637
Liu, Geng Tao 1992: Anti-oxidant activity of dibenzocyclooctene lignans isolated from Chinese herbs. Yagi, K, Kondo, M, Niki, E, Yoshikawa, T International Congress Series; Oxygen radicals: 805-808
Miniyar,P.B.; Chitre,T.S.; Karve,S.S.; Deuskar,H.J.; Jain,K.S. 2008: Anti-oxidant activity of ethyl acetate extract of Aquilaria agallocha on nitrite-induced methemoglobin formation. International Journal Of Green Pharmacy: 1, 43-45
Tournaire, C.; Hocquaux, M.; Beck, I.; Oliveros, E.; Maurette, M.T.erese 1994: Anti-oxidant activity of flavonoids Reactivity with potassium superoxide in heterogeneous phase. Tetrahedron 50(31): 9303-9314
Fang, S-Hua.; Rao, Y.Koteswara.; Tzeng, Y-Min. 2008: Anti-oxidant and inflammatory mediator's growth inhibitory effects of compounds isolated from Phyllanthus urinaria. Journal of Ethnopharmacology 116(2): 333-340
Ohshima, H.; Yoshie, Y.; Auriol, S. 1998: Anti-oxidant and pro-oxidant properties of flavonoids Effects on DNA damage induced by nitric oxide and peroxynitrite. Proceedings of the American Association for Cancer Research 39: 371
Tikhomirova, O.V.; Rodionova, O.V.; Ivanova, V.V.; Dubinina, E.E.; Kurbatova, G.P.; Govorova, L.V.; Zheleznikova, G.F.; Mikheeva, I.A. 1998: Anti-oxidant biopreparation in complex treatment of pharyngeal infections in children Experience of local usage. Pediatriya (Moscow) 1998(2): 73-76
Matsufuji, H.; Ishikawa, K.; Nunomura, O.; Chino, M.; Takeda, M. 2007: Anti-oxidant content of different coloured sweet peppers, white, green, yellow, orange and red Capsicum annuum L. International Journal of Food Science & Technology 42(12): 1482-1488
Fields, J.Z.; Robinson, C.E.; Keshavarzian, A.; Rawal, P.A.; Hagen, J.F.; Wallace, R.K.; Tomlinson, P.F.; Schneider, R.H. 1994: Anti-oxidant effects of an anti-carcinogenic, natural product-Maharishi Amrit Kalash. Age 17(4): 163-164
Das, D.; Pemberton, P.; Burrows, P.; Gordon, C.; Smith, A.; Warnes, T.W. 1998: Anti-oxidant effects of colchicine. Journal of Hepatology 28(Suppl 1): 165
Kelkar, H.S.; Scheffer, R.; Correnti, E.E.; Mukherjee, S.; Mahadik, S.P. 1993: Anti-oxidant enzyme defense system is altered in erythrocytes from first-episode drug-naive schizophreniform patients. Society for Neuroscience Abstracts 19(1-3): 202
Lim, H.L.; Myers, B.M.; Hamilton, B.A.; Davis, G.L.; Lau, J.Y.N. 1994: Anti-oxidant enzyme status in chronic hepatitis C virus infection. Gastroenterology 106(4 Suppl): A932
Hellberg, M.; Delgado, P.; Nixon, J.C. 1998: Anti-oxidant esters of non-steroidal anti-inflammatory agents. Official Gazette of the United States Patent and Trademark Office Patents 1210(2): 1556
Mahomed, A.G.; Anderson, R.; Theron, A.J.; Feldman, C. 1996: Anti-oxidant interactions of theophylline and aminophylline with human neutrophils in vitro are related to cyclic AMP elevation. European Respiratory Journal Suppl 9(23): 401S
Das, D.; Pemberton, P.; Burrows, P.; Gordon, C.; Smith, A.; Mcmahon, R.F.T.; Warnes, T.W. 1997: Anti-oxidant markers in chronic CCl-4 injury in rats. Hepatology 26(4 Part 2): 234A
NaveenKumar; Srivastava,G.C. 2008: Anti-oxidant metabolism during rose petal senescence. Journal Of Horticultural Science And Biotechnology: 6, 755-759
Peters, E.M.; Goetzsche, J.M.; Joseph, L.E.; Noakes, T.D. 1994: Anti-oxidant nutrient supplementation and symptoms of upper respiratory tract infections in endurance athletes. Medicine and Science in Sports and Exercise 26(5 Suppl): S218
Williams, M.D.; Cheeseman, J.M. 1996: Anti-oxidant photoprotection in mangroves From cells to chloroplasts to thylakoids. Plant Physiology (Rockville) 111(2 Suppl): 93
Denton, C.P.; Bunce, T.; Wilson, H.; Howell, K.; Bruckdorfer, K.R.; Black, C.M. 1996: Anti-oxidant therapy for Raynauds phenomenon - a controlled trial comparing probucol with nifedipine. Arthritis and Rheumatism 39(9 Suppl): S152
Eralinna, J.P.; Setala, N.; Roytta, M.; Soppi, E.; Salmi, A.A.; Panelius, M.; Salonen, R. 1997: Anti-oxidant therapy with tirilazad mesylate reduces autoimmune CNS demyelination in experimental allergic encephalomyelitis. Journal of the Neurological Sciences 150(Suppl ): S185
Arinola,O.G.; Akinosun,A.M. 2008: Anti-oxidant vitamins, nitric oxide and acute phase proteins in Nigerian cigarette smokers. African Journal Of Biomedical Research: 3, 291-295
Altura, B.M.; Gebrewold, A. 1997: Anti-oxidant, alpha-tocopherol, ameliorates alcohol-induced cerebral vascular damage in rat brains in vivo. Alcoholism Clinical and Experimental Research 21(3): 88A
Seelinger, G.ün.; Merfort, I.; Schempp, C.M. 2008: Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin. Planta Medica 74(14): 1667-1677
Ruan, J.; Ehrt, S.; Shiloh, M.; Xie, Q.W.; Riley, L.; Nathan, C. 1997: Anti-oxidant/anti-nitrosative gene from mycobacterium tuberculosis Functional characterization in E coli and S typhimurium. Japanese Journal of Pharmacology 75(Suppl 1): 14P
Chuang, D.M.; Leeds, P.; Zhang, K.G.; Gao, X.M.; Ishitani, R. 1995: Anti-oxidants and NMDA receptor antagonists protect against age-induced apoptosis in cerebellar granule cells. Society for Neuroscience Abstracts 21(1-3): 1553
Hunt, N.H.; Fragonas, J.C.; Kneale, C.L.; Jeitner, T.M.; Van Reyk, D.M. 1992: Anti-oxidants and T-cell activation. Yagi, K, Kondo, M, Niki, E, Yoshikawa, T International Congress Series; Oxygen radicals: 719-722
McGowan, A.J.; Fernandes, R.S.; Samali, A.; Cotter, T.G. 1996: Anti-oxidants and apoptosis. Biochemical Society Transactions 24(1): 229-233
Ubbink, J.B.; Vermaak, W.J. 1995: Anti-oxidants and coronary heart disease. South African Medical Journal 85(12): 1279-1281
Harada, T.; Luo, Z.; Gajdusek, C.; London, S.; Mayberg, M.R. 1993: Anti-oxidants and iron chelating agents in cerebral vasospasm. Canadian Journal of Neurological Sciences 20(Suppl 1): S12
Warwick, G.L.; Waller, H.; Ferns, G.A.A. 1998: Anti-oxidants and lipidoprotein oxidation in nephrotic syndrome. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 101A
Chen, S.S.; Gong, J. 1998: Anti-oxidants present in tobacco leaves protect against IgE-mediated allergic inflammation. FASEB Journal 12(5): A1063
Ishiguro,K.; Yoshimoto,M.; Suzuki,M.; Yahara,S. 2008: Anti-oxidative activity in the lipophilic fraction of sweet potato tubers. Acta Horticulturae 798: 571-577
Shim, J.-U.; Lim, K.-T. 2008: Anti-oxidative and anti-proliferative character of glycoprotein isolated from geranium sibiricum linne in Chang liver cells. Environmental Toxicology and Pharmacology 26(3): 320-324
Kim, S.K.; Kim, H.J.; Choi, S.E.; Park, K.H.; Choi, H.K.; Lee, M.W. 2008: Anti-oxidative and inhibitory activities on nitric oxide (NO) and prostaglandin E2 (COX-2) production of flavonoids from seeds of Prunus tomentosa Thunberg. Archives of Pharmacal Research 31(4): 424-428
KimSungKyu; KimHyunJung; ChoiSunEun; ParkKwanHee; ChoiHyungKyun; LeeMinWon 2008: Anti-oxidative and inhibitory activities on nitric oxide and prostaglandin E2 production of flavonoids from seeds of Prunus tomentosa Thunberg. Archives Of Pharmacal Research: 4, 424-428
Koh, J.Y.; Kim, D.K.; Kim, Y.H.; Hwang, J.Y. 1998: Anti-oxidative but pro-apoptotic effects of riluzole on cultured cortical neurons. Journal of Neurochemistry 70(Suppl 2): S28
Masukawa, T.; Tetsumi, T.; Katakawa, J.'ichi 1993: Anti-oxidative effect of dialkyldithiocarbamates. Japanese Journal of Pharmacology 61(Suppl 1): 275P
Singh,V.; Jain,V.K.; RakeshKumar; Sridhar 2008: Anti-oxidative effects of ascorbic acid on buffalo erythrocytes in vitro. Indian Journal Of Animal Sciences: 9, 919-921
Rebic, R.; Rebic, P.; Djurdjic, V.; Mitic Milikic, M. 1995: Anti-oxidative enzymes in chronic obstructive pulmonary disease. European Respiratory Journal 8(Suppl 19): 569S
Miyajima, T.; Yoshikawa, T.; Ichikawa, H.; Minamiyama, Y.; Tsujigiwa, M.; Nakahashi, Y.; Takahashi, S.; Kondo, M. 1994: Anti-Oxidative Properties of Ginkgo Biloba Extract. Asada, K, Yoshikawa, T International Congress Series; Frontiers of reactive oxygen species in biology and medicine 341-342
Wang, S-Hua.; Zhang, H.; Fu, M-Qin.; Chen, Q-Yu.; Zhou, Z-Yi.; Lu, X-Min. 2007: Anti-oxidative responses of Agrocybe aegerita mycelia to cadmium stress. Ying Yong Sheng Tai Xue Bao 18(8): 1813-1818
Frenkel, K.; Glassman, T.; Karkoszka, J.; Taioli, E. 1994: Anti-oxidized DNA base autoantibodies as a potential biomarker of high risk for the development of human breast cancer. Proceedings of the American Association for Cancer Research 35: 97
Garrido-Sánchez, L.; Cardona, F.; García-Fuentes, E.; Rojo-Martínez, G.; Gómez-Zumaquero, J.M.; Picón, M.J.; Soriguer, F.; Tinahones, F.J. 2008: Anti-oxidized low-density lipoprotein antibody levels are associated with the development of type 2 diabetes mellitus. European Journal of Clinical Investigation 38(9): 615-621
Summaria, F.; Monaco, C.; Niccoli, G.; Teoli, R.; Bellomo, G.; Perugini, C.; Bagnati, M.; Buffon, A.; Liuzzo, G.; Caligiuri, G.; Crea, F.; Maseri, A. 1998: Anti-oxidized-LDL antibodies as a possible cause of inflammation in unstable angina. Journal of the American College of Cardiology 31(2 Suppl A): 450A
Burlakova, E.B.; Dzyuba, N.M.; Pal'mina, N.P.; Emanuel', N.M. 1965: Antioxidative activity of lipids of mouse liver in radiation disease and reinoculation leucosis, and the effect of inhibitors of free-radical reactions. Doklady Akademii Nauk SSSR 163(5): 1278-1281
Saji, F.; Azuma, C.; Kimura, T. 1996: Anti-oxytocin receptor antibodies. Official Gazette of the United States Patent and Trademark Office Patents 1188(5): 3680
Haydon, G.H.; Bouchier, I.A.D.; Hayes, P.C. 1996: Anti-p-53 autoantibodies in patients from an area of low prevalence of hepatocellular carcinoma. Gastroenterology 110(4 Suppl): A1208
Ohno, A.; Takeda, K.; Kadota, Y.; Nitta, T.; Takifuji, N.; Terakawa, K.; Kishi, A.; Yamamoto, R.; Tada, T.; Negoro, S.; IIoka, S.; Fukuoka, M. 1996: Anti-p53 antibodies in sera of small cell lung cancer patients before and after treatment with chemotherapy. Proceedings of the American Association for Cancer Research 37: 206
Li, Y.; Brandt Rauf, P.W.; Carney, W.P.; Ford, J.G. 1998: Anti-p53 antibody distribution and relationship to smoking in lung cancer. Proceedings of the American Association for Cancer Research 39: 630
Volkmann, M.; Mueller, M.; Meyer, M.; Ulsperger, E.; Lehnert, T.; Fiehn, W.; Zentgraf, H.; Galle, P.R. 1995: Anti-p53 autoantibodies as serological marker in different tumor-entities. Clinical Chemistry 41(S6 Part 2): S221-S222
Sthoeger, Z.; Evron, E.; Goland, S.; Shani, A.; Wolkowicz, R.; Goldfinger, N.; Rotter, V.; Fogel, M. 1997: Anti-p53 autoantibodies in colon cancer patients. Annals of the new York Academy of Sciences 815: 496-498
Feil, G.; Petri, E.; Nelde, H.J.; Wechsel, H.W.; Bichler, K.Horst; Knobloch, J. 1998: Anti-p53 autoantibodies in patients with schistosomiasis. Journal of Urology 159(5 Suppl): 311
Suppiah, A.; Alabi, A.; Madden, L.; Hartley, J.E.; Monson, J.R.T.; Greenman, J. 2008: Anti-p53 autoantibody in colorectal cancer: prognostic significance in long-term follow-up. International Journal of Colorectal Disease 23(6): 595-600
Hara, T.; Ogawa, F.; Muroi, E.; Komura, K.; Takenaka, M.; Hasegawa, M.; Fujimoto, M.; Sato, S. 2008: Anti-p53 autoantibody in systemic sclerosis: association with limited cutaneous systemic sclerosis. Journal of Rheumatology 35(3): 451-457
Mueller, M.; Meyer, M.; Volkmann, M.; Rath, U.; Kommerell, B.; Galle, P.R. 1993: Anti-p53 serum antibodies in patients with hepatocellular carcinoma and GI-tract tumors Clinical relevance and diagnostic usefulness. Hepatology 18(4 Part 2): 190A
Godfrey, D.G. 1957: Antiparasitic action of dietary cod liver oil upon Plasmodium berghei and its reversal by vitamin E. Experimental Parasitology 6(6): 555-565
Medlen, C.E.; Anderson, R. 1998: Anti-parasitic activity. Official Gazette of the United States Patent and Trademark Office Patents 121(2): 1703
Kouri, A. 1959: Anti-parasitic therapy Chilomastix mesnili,. Rev Kuba Med Trop Y Parasitol 12: 52-54
Kouri, A. 1959: Anti-parasitic therapy Intestinal trichomoniasis. Rev Kuba Med Trop Y Parasitol 12: 54-58
Slusher, B.S.; Rissolo, K.C.; Jackson, P.F.; Pullan, L.M. 1993: Anti-parkinsonian effects of centrally-administered glycine antagonists. Society for Neuroscience Abstracts 19(1-3): 1353
Bahyrycz,A.; Saniewska,A.; Konopinska,D. 2008: Anti-pathogenic properties of plant peptide hormone phytosulfokines and its selected analogues. Pestycydy: 2, 109-117
Ryals, J.A.; Gay, P.B.; Ahl Goy, P.A. 1997: Anti-pathogenically effective compositions comprising lytic peptides and hydrolytic enzymes. Official Gazette of the United States Patent and Trademark Office Patents 1198(3): 1781
Vilter, R.W.; Spies, T.D. 1939: Anti-pellagric properties of quinolinic acid. Lancet 237(6051): 423
Wallukat, G.; Fu, M.L.X.; Hjalmarson, A.; Hoebeke, J. 1994: Anti-peptide antibodies against human heart muscarinic receptor with agonist effect without desensitization. Circulation 90(4 Part 2): I66
Hamilton, S.R.; Yao, S.Y.M.; Ingram, J.; Henderson, P.J.F.; Gallagher, M.P.; Cass, C.E.; Young, J.D.; Baldwin, S.A. 1997: Anti-peptide antibodies as probes of the structure and subcellular distribution of the sodium dependent nucleoside transporter, rCNT1. Journal of Physiology (Cambridge) 499P: 50P-51P
Pop Busui, R.; Towns, R.; Larkin, D.A.; Killen, P.D.; Greene, D.A. 1998: Anti-peptide antibodies detect distinct sodium-dependent myo-inositol co-transporter isoforms in human retinal pigment epithelial cells. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 56A
Nakagawa, M.; Ohmido, N.; Ishikawa, K.; Uchiyama, S.; Fukui, K.; Azuma, T. 2008: Anti-peptide antibodies for examining the conformation, molecular assembly and localization of an intracellular protein, ribosomal protein S6, in vivo. Journal of Biochemistry 143(3): 325-332
Van Ginkel, F.W.; Mcghee, J.R.; Kiyono, H.; Bost, K.L.; Pascual, D.W. 1993: Anti-peptide antibodies to rat brain substance P receptor recognize both brain and lymphoid SP receptors. Journal of Immunology 150(8 Part 2): 198A
Abd Alla, S.; Grigoriev, S.; Maidhof, A.; Figueroa, C.; Jarnagin, K.; Mueller Esterl, W. 1994: Anti-peptide antibodies to the bradykinin B2 receptor. Naunyn-Schmiedeberg's Archives of Pharmacology 349(Suppl): R90
Tamura, T.; Tomimatsu, K.; Katakura, Y.; Yamashita, M.; Matsumoto, S.-e.; Aiba, Y.; Jung, Y.S.; Abe, Y.; Fujiki, T.; Teruya, K.; Shirahata, S. 2007: Anti-peptide antibody production elicited by in vitro immunization of human peripheral blood mononuclear cells. Bioscience Biotechnology and Biochemistry 71(12): 2871-2875
Gotti, C.; Moretti, M.; Longhi, R.; Briscini, L.; Manera, E.; Clementi, F. 1993: Anti-peptide specific antibodies for the characterization of different alpha subunits of alpha-bungarotoxin binding acetylcholine receptors present in chick optic lobe. Journal of Receptor Research 13(1-4): 453-465
Carrillo, J.; Puertas, M.C.; Planas, R.; Pastor, X.; Alba, A.; Stratmann, T.; Pujol-Borrell, R.; Ampudia, R.M.; Vives-Pi, M.; Verdaguer, J. 2008: Anti-peripherin B lymphocytes are positively selected during diabetogenesis. Molecular Immunology 45(11): 3152-3162
ChuangPeiTing; ShenSzuChuan; WuNingJung; Wu,J.S.B. 2008: Anti-peroxidation effect of guava leaf soluble solids in vitro and in streptozotocin/nicotinamide-induced diabetic rats. Journal Of The Science Of Food And Agriculture: 12, 2173-2179
Sathivel, A.; Raghavendran, H.R.B.; Srinivasan, P.; Devaki, T. 2008: Anti-peroxidative and anti-hyperlipidemic nature of Ulva lactuca crude polysaccharide on D-galactosamine induced hepatitis in rats. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 46(10): 3262-3267
Kakoki, H.; Kono, Y.; Funatsu, S.; Komatsu, M. 1995: Anti-peroxide external preparation for skin. Official Gazette of the United States Patent and Trademark Office Patents 1174(3): 1854
Borisov, L.B. 1964: Anti-phage action of ethylenimines. Byul Eksp Biol Med 57(3): 78-81
Zuev, V.A. 1963: Anti-phage and anti-bacterial activity of carcinostatic agents Dichloroethylamine and its derivatives. Vopr Virusol: 650-662
Osamu-Matsuura; Takeshi-Yamanaka; Hisanori-Fukushima 2007: Anti-phagocytic effect of mannose-rich exopolysaccharide from a biofilm-forming strain of Prevotella intermedia. Shika Igaku 70(2): 141-150
Chrosch Jutta; Bismayer Ulrich; Salje Ekhard, K.H. 1997: Anti-phase boundaries and phase transitions in titanite; an X-ray diffraction study. American Mineralogist 82(7-8): 677-681
Valentine, J.L.; Wessinger, W.D.; Owens, S.M. 1994: Anti-phencyclidine monoclonal Fab fragments dramatically decrease phencyclidine neurotoxicity in Sprague-Dawley rats. Society for Neuroscience Abstracts 20(1-2): 1046
Ordi, J.; Balada, E.; Martinez, N.; Paredes, J.; Villarreal, J.; Labrador, M.; Vilardell, M. 1998: Anti-phosphatidylethanolamine antibodies as a marker for the antiphospholipid syndrome. Arthritis and Rheumatism 41(9 Suppl): S171
Faiderbe, S.; Chagnaud, J.L.; Geffard, M. 1995: Anti-phosphatidylinositol autoantibodies and malignant tumours. Nouvelle Revue Francaise d'Hematologie 37(Suppl 2): S104-S105
Manttari, M.; Puurunen, M.; Manninen, V.; Palosuo, T.; Vaarala, O. 1998: Anti-phosphatidylserine antibodies and the risk of myocardial infarction and coronary death. Circulation 98(17): I170
Adam, L.P.; Wrangle, J.; D'angelo, G. 1997: Anti-phosphocaldesmon antibodies detect caldesmon phosphorylation in carotid arteries and A10 cells. Molecular Biology of the Cell 8(Suppl ): 376A
Pittoni, V.; Ravirajan, C.T.; Isenberg, D.A. 1998: Anti-phospholipid and anti-DNA human monoclonal antibodies bind monoblastoid cell line U937 undergoing apoptosis. British Journal of Rheumatology 37(ABSTR Suppl 1): 73
Pittoni, V.; Ravirajan, C.T.; Donohoe, S.; Mackie, I.J.; Machin, S.J.; Lydyard, P.; Isenberg, D.A. 1998: Anti-phospholipid and anti-beta2-glycoprotein I human monoclonal antibodies bind a monoblastoid cell line undergoing apoptosis. Lupus 7(Suppl 2): S175
Bodiguel, E. 1992: Antiphospholipid antibodies and the central nervous system. Revue Neurologique (Paris) 148(11): 655-662
Spronk, P.E.; Overbosch, E.O.; Schut, N.H. 1998: Anti-phospholipid antibodies and severe atherosclerosis; cause of sequel?. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 357A
Manfredi, A.A.; Rovere, P.; Heltai, S.; Nebbia, G.; Tincani, A.; Balestrieri, G.; Rugarli, C.; Sabbadini, M.G. 1996: Anti-phospholipid antibodies bind apoptotic cells in a beta-2-GPI dependent fashion. Lupus 5(5): 558
Hirashima, Y.; Endo, S.; Kurimoto, M.; Tsukamoto, E.; Takaku, A. 1993: Anti-phospholipid antibodies in cerebral vasospasm following subarachnoid hemorrhage. Canadian Journal of Neurological Sciences 20(Suppl 1): S20
Facer, C.A.; Agiostratidou, G. 1995: Anti-phospholipid antibodies in malaria What, when and why?. Annals of Tropical Medicine and Parasitology 89(2): 173
Sierakowski, S.; Bernacka, K.; Chwiecko, J.; Urban, J.; Przepiesc, J.; Swiec, M.; Kaminska, M.; Litorowicz, A.; Picewicz Gozdzikiewicz, B.; Lachowicz, M. 1996: Anti-phospholipid antibodies in serum of pregnant and non-pregnant women. Reumatologia 34(2-3 Part 1): 215-219
Mccarty Farid, G.A.; Simpson, N.M.; Lister, K.L.; Mcconathy, W.J. 1992: Anti-phospholipid autoantibodies and plasma lipoproteins. Arthritis and Rheumatism 35(9 Suppl): S362
Church, H.; Brown, S.; Ren, Y.; Loziou, S.; Walport, M.; Savill, J. 1997: Anti-phospholipid autoantibody-positive sera interfere with phosphatidylserine -dependent recognition of apoptotic cells by macrophages. Clinical Science 93(2): 8P
Inoue, K.; Umeda, M.; Igarashi, K.; Reza, F.; Tokita, S.; Yamaji, A.; Asaoka, Y. 1994: Anti-phospholipid monoclonal antibody as a structural template for studying lipid-protein interactions. Journal of Cellular Biochemistry Suppl 1994(18D): 24
Lieck, P.; Zierhut, M.; Klein, R.; Berg, P.; Tuermer, K.H. 1994: Anti-phospholipid-antibody in uveitis and vascular disease. IOVS Investigative Ophthalmology and Visual Science 35(4): 1884
Adam, L.P.; Wrangle, J.; D'angelo, G. 1998: Anti-phosphopeptide antibodies detect caldesmon phosphorylation in carotid arteries and cultured smooth muscle cells. Biophysical Journal 74(2 Part 2): A39
Bochow, H. 1967: Anti-phytopathogenic effects of the soil and their use in plant protection. Nachrichtenbl Deut Pflanzenschutzdienst 21(6): 101-106
Hammond, M.; Kaldor, S.W. 1996: Anti-picornaviral agents. Official Gazette of the United States Patent and Trademark Office Patents 1186(1): 472
Stromberg, S.; O'dwyer, D.; Hulting, A.L.; Crock, P. 1997: Anti-pituitary autoantibodies in Turner syndrome. Hormone Research 48(Suppl 2): 189
Hundley, J.M.; Nasi, K.W. 1944: Anti-plague measures in Tacoma, Washington. Public Health Reports 59(88): 1239-1255
Petri, M.; Miller, J.; Goldman, D.; Ebert, R. 1994: Anti-plasma protein antibodies are predictive of thrombotic events. Arthritis and Rheumatism 37(9 Suppl): S281
Shimada, E.; Suzuki, M.; Shiamno, K.; Arai, N.; Shinoda, T.; Mitsunaga, S.; Tadokor, K.; Juji, T. 1998: Anti-plasma protein antibodies detected in patients with nonhemolytic tranfusion reactions using 2D-PAGE and western blotting. Vox Sanguinis 74(Suppl 1): 85
Rukunga, G.M.; Muregi, F.W.; Omar, S.A.; Gathirwa, J.W.; Muthaura, C.N.; Peter, M.G.; Heydenreich, M.; Mungai, G.M. 2008: Anti-plasmodial activity of the extracts and two sesquiterpenes from Cyperus articulatus. Fitoterapia 79(3): 188-190
Sato, S.; Shirahata, A.; Maehara, J.; Yamada, T.; Tomioka, K.; Asano, M. 1993: Anti-platelet activating factor activity of YM264 in vivo. Japanese Journal of Pharmacology 61(Suppl 1): 206P
Nakahara, I.Y.S.iba; Matsuhisa, M.; Tomita, T.; IIda, M.; Ikeda, M.; Kubota, M.; Yamasaki, Y.; Hori, M. 1998: Anti-platelet agent, cilostazol, improves metabolic derangement of glucose in obese NIDDM model rats. Diabetologia 41(Suppl 1): A193
Poelstra, K.; Baller, J.F.W.; Hardonk, M.J.; Bakker, W.W. 1992: Anti-platelet agents prevent proteinuria during experimental glomerulonephritis in rats. Journal of the American Society of Nephrology 3(3): 662
Huang, H-Chi.; Tsai, W-Jern.; Liaw, C-Ching.; Wu, S-Hsiung.; Wu, Y-Chang.; Kuo, Y-Haur. 2007: Anti-platelet aggregation triterpene saponins from the galls of Sapindus mukorossi. Chemical and Pharmaceutical Bulletin 55(9): 1412-1415
Shibata, Y.; Morita, S. 1996: Anti-platelet alloantibodies in Japanese detected by MPHA. Vox Sanguinis 70(Suppl 2): 55
Orieby, A.M.; Hamed, E.M. Shawky; Ibrahim, M.S.; Hablas, R.A. Hamid 1992: Anti-platelet autoantibodies in Bilharzial hepatosplenomegalic patients. Egyptian Journal of Bilharziasis 13(1-2): 69-81
Tsao, P.S.; Singer, A.H.; Ohno, M.; Kaplan, A.V.; Leung, L.L.K.; Cooke, J.P. 1993: Anti-platelet effect of dietary L-arginine, the nitric oxide precursor. Journal of the American College of Cardiology 21(2 Suppl A): 125A
Yamane, Y.ko; Goto, Jun; Hitomi, Takehiko; Tanaka, Makoto; Takahashi, Teisuke; Araki, Hiroaki; Higuchi, Shohei 1996: Anti-platelet effects of PS-028, a novel platelet GP IIb/IIIa antagonist. Japanese Journal of Pharmacology 71(Suppl 1): 149P
Kim, J.M.; Yun-Choi, H.S. 2008: Anti-platelet effects of flavonoids and flavonoid-glycosides from Sophora japonica. Archives of Pharmacal Research 31(7): 886-890
Takahashi, M.; Amano, M.; Matsumoto, T.; Omura, T.; Kinoshita, M. 1997: Anti-platelet effects of nitric oxide releasing substance, NOC-7 resembles stabilized nitric oxide. Japanese Journal of Pharmacology 75(Suppl 1): 108P
Weisman, H.F.; Schaible, T.F.; Jordan, R.E.; Cabot, C.F.; Anderson, K.M. 1995: Anti-platelet monoclonal antibodies for the prevention of arterial thrombosis: experience with ReoPro, a monoclonal antibody directed against the platelet GPIIb/IIIa receptor. Biochemical Society Transactions 23(4): 1051-1057
Gralnick, H.R. 1994: Anti-platelet monoclonal antibody. Official Gazette of the United States Patent and Trademark Office Patents 1168(4): 2537
Collins, C.E.; Forbes, A.; Rampton, D.S. 1995: Anti-platelet therapy in active Crohns disease An open trial using picotamide, a thromboxane antagonist. Gastroenterology 108(4 Suppl): A799
Tsoupras,A.B.; Chini,M.; Tsogas,N.; Fragopoulou,E.; Nomikos,T.; Lioni,A.; Mangafas,N.; Demopoulos,C.A.; Antonopoulou,S.; Lazanas,M.C. 2008: Anti-platelet-activating factor effects of highly active antiretroviral therapy a new insight in the drug therapy of HIV infection?. Aids Research And Human Retroviruses: 8, 1079-1086
Kaburaki, J.; Kuwana, M.; Kawai, S.; Ikeda, Y. 1997: Anti-platelet-glycoprotein antibodies and thrombocytopenia in anti-phospholipid syndrome. Arthritis and Rheumatism 40(9 Suppl): S104
Cruckshank, A.H.; Payne, T.P.B. 1949: Anti-pneumococcal powers of blood in alloxan diabetes in the rabbit. Bull Johns Hopkins Hosp 84(4): 334-343
Patrick, D.A.; Hall, J.E.; Bender, B.C.; Mccurdy, D.R.; Tidwell, R.R. 1998: Anti-pneumocystic carinii pneumonia activity of dicationic dibenzothiophenes. Abstracts of Papers American Chemical Society 216(1-3): MEDI 238
Hann, H.W.L.; Song, J.; Feitelson, M.A. 1997: Anti-pol and HBxAg markers in the sera of patients with primary hepatocellular carcinoma. Hepatology 26(4 Part 2): 243A
Mande, R.; Therond, C. 1959: Anti-polio vaccination of allergic children. Arch Franc Pediatrie 16(9): 1244-1247
Pattyn, S.R. 1964: Anti-Poliomyelitic Vaccination in Tropical Countries. Tropical and Geographical Medicine 16: 4-9
Mausner, J. 1996: Anti-pollution cosmetic composition. Official Gazette of the United States Patent and Trademark Office Patents 1192(1): 362-363
Cheng, S.L. 1996: Anti-pollution system. Official Gazette of the United States Patent and Trademark Office Patents 1192(1): 77
Marotta, F.; Chui, D.H. 1992: Anti-polymorphonuclear cells globulin reduces the flare-up of acute pancreatitis in rats. Digestion 52(2): 103-104
Goetz, J.; Hauptmann, G. 1993: Anti-polymorphonuclear-neutrophil-cytoplasm antibodies Methods for detection, diagnostic value. Journal de Medecine de Strasbourg 24(10): 341-343
Walter, E.B.; Simmons, S.S.; Clements, D.A. 1994: Anti-polyribosylribitol phosphate antibody levels 5 years after a primary series of Haemophilus influenzae type B conjugate vaccine. Journal of Infectious Diseases 170(4): 1050-1051
Go, E.S.; Ballas, Z.K. 1995: Anti-polysaccharide antibody response in normal subjects A meta-analysis. Journal of Allergy and Clinical Immunology 95(1 Part 2): 240
Biscardi, K.; Becker, R. 1993: Anti-polysaccharide responses in mice co-administered with polysaccharide conjugates and carrier proteins. Journal of Immunology 150(8 Part 2): 149A
Couratier, P.; Swan, M.; Yi, F.H.; Beaume, A.; Mariette, X.; Singer, B.; Preud Homme, J.L.; Vincent, D.; Vallat, J.M.; Jauberteau, M.O. 1998: Anti-polysialylated ganglioside IgM are associated with a subgroup of relapsing chronic inflammatory demyelinating polyneuropathies. Neurology 50(4 Suppl 4): A144-A145
Sidorkiewicz, M. 1997: Anti-preS1 antibody in HBV DNA positive and negative sera from patients with acute hepatitis B. Central-European Journal of Immunology 22(3): 200
Wisenden, B., D.; Karst, J.; Miller, J.; Miller, S.; Fuselier, L. 2008: Anti-predator behaviour in response to conspecific chemical alarm cues in an esociform fish, Umbra limi Kirtland 1840. Environmental Biology of Fishes 82(1): 85-92
Beani, L.; Dessi Fulgheri, F. 1998: Anti-predator behaviour of captive Grey partridges. Ethology Ecology and Evolution 10(2): 185-196
Bongi,P.; Ciuti,S.; Grignolio,S.; Frate,M.del; Simi,S.; Gandelli,D.; Apollonio,M. 2008: Anti-predator behaviour, space use and habitat selection in female roe deer during the fawning season in a wolf area. Journal of Zoology 6(3): 242-251
Nelson,X.J.; Jackson,R.R. 2008: Anti-predator creches and aggregations of ant-mimicking jumping spiders. Biological Journal Of The Linnean Society: 3, 475-481
Luening, J. 1994: Anti-predator defenses in Daphnia Are life-history changes always linked to induced neck spines?. Oikos 69(3): 427-436
Datta, A. 1998: Anti-predatory response of the Indian giant squirrel Ratufa indica to predation attempts by the crested hawk eagle Spizaetus cirrhatus limnaetus. Journal of the Bombay Natural History Society 95(2): 332-335
Pilon, J.; Loiacono, C.; Okeson, D.; Lund, S.; Vercauteren, K.; Rhyan, J.; Miller, L. 2007: Anti-prion activity generated by a novel vaccine formulation. Neuroscience Letters 429(2-3): 161-164
Miyake, T.; Pincus, G. 1958: Anti-progestational activity of estrogens in rabbit endometrium. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 99(2): 478-482
Ohtani, M.; Shiraiwa, H.; Miyanaga, N.; Akaza, H.; Koiso, K.; Tsutsumi, M.; Tobisu, K.I.; Kakizoe, T. 1995: Anti-progressive effects of azatyrosine on murine bladder carcinoma. Journal of Urology 153(4 Suppl): 521A
Mita, A.; Ricordi, C.; Miki, A.; Barker, S.; Haertter, R.; Hashikura, Y.; Miyagawa, S.-I.; Burke, G.W.; Inverardi, L.; Ichii, H. 2008: Anti-proinflammatory effects of sirolimus on human islet preparations. Transplantation 86(1): 46-53
Olukoga, A.O.; Kane, J. 1995: Anti-prolactin autoantibodies and hyperprolactinaemia. European Journal of Endocrinology 133(4): 463-464
Hattori, N.; Inagaki, C. 1997: Anti-prolactin autoantibody is a new cause of hyperprolactinemia in which bromocriptine therapy is not required. Japanese Journal of Pharmacology 73(Suppl 1): 103P
Ban, J.Ok.; Hwang, I.Guk.; Kim, T.Myoung.; Hwang, B.Yeon.; Lee, U.Soo.; Jeong, H-Sang.; Yoon, Y.Won.; Kimz, D.Joong.; Hong, J.Tae. 2007: Anti-proliferate and pro-apoptotic effects of 2,3-dihydro-3,5-dihydroxy-6-methyl-4H-pyranone through inactivation of NF-kappaB in human colon cancer cells. Archives of Pharmacal Research 30(11): 1455-1463
Chinnadurai, G. 1998: Anti-proliferation domain of a human BCL-2 and DNA encoding the same. Official Gazette of the United States Patent and Trademark Office Patents 1215(2): 1788
QuGePing; LiBing; XiuQingYu; ZhangLingZhen 2008: Anti-proliferation effect of arsenic trioxide on human lung adenocarcinoma cell line A549 under hypoxia condition. Chinese Journal Of Cancer Biotherapy: 3, 273-277
ZhouLinLi; ChanYuetWa; WangJun; FungKwokPui 2008: Anti-proliferation of MDA-MB-231 human breast tumour cells by arsenic trioxide via induction of apoptosis. Research Journal Of Medical Sciences: 5, 236-243
Deepa, T.; Prasad, P.; Sidhu, G.S.; Maheshwari, R.K. 1994: Anti-proliferative action of curcumin. Molecular Biology of the Cell 5(Suppl ): 313A
Nurhanan,M.Y.; Asiah,O.; MohdIlham,M.A.; SitiSyarifah,M.M.; Norhayati,I.; LiliSahira,H. 2008: Anti-proliferative activities of 32 Malaysian plant species in breast cancer cell lines. Journal of Tropical Forest Science 20(2): 77-81
Yang, C.S.; Yang, G.Y.; Landau, J. 1997: Anti-proliferative and anti-carcinogenic activities of black tea and tea polyphenols. Abstracts of Papers American Chemical Society 213(1-3): AGFD 169
Akhtar, M.N.; Thomson, D.S.; Arora, S.K. 1995: Anti-proliferative and anti-inflammatory compounds Derivatives of pentose monosaccharides. Official Gazette of the United States Patent and Trademark Office Patents 1176(2): 1151
Descalzi, D.; Folli, C.; Nicolini, G.; Riccio, A.M.; Gamalero, C.; Scordamaglia, F.; Canonica, G.W. 2008: Anti-proliferative and anti-remodelling effect of beclomethasone dipropionate, formoterol and salbutamol alone or in combination in primary human bronchial fibroblasts. Allergy 63(4): 432-437
Zi, X.; Agarwal, R. 1998: Anti-proliferative and apoptotic effects of a potent cancer preventive agent silymarin are mediated via distinct signals involving respectively ERK and JNK pathways. Proceedings of the American Association for Cancer Research 39: 291
Wu, B.; Zhang, Q.; Shen, W.; Zhu, J. 2008: Anti-proliferative and chemosensitizing effects of luteolin on human gastric cancer AGS cell line. Molecular and Cellular Biochemistry 313(1-2): 125-132
Adams, V.R.; Kuhn, J.G.; Tami, J.A. 1994: Anti-proliferative and cytotoxic effects of ciprofloxacin and ofloxacin on two human bladder carcinoma cell lines. Pharmacotherapy 14(3): 360
Zhang, J.M.; Sieber Blum, M. 1992: Anti-proliferative and neurogenic effect by TGF-beta-1 on neural crest cells override mitogenic and adrenogenic effects exerted by the bFGF/NGF peptide factor combination. Molecular Biology of the Cell 3(Suppl ): 285A
Sa, F.; Gao, J.-L.; Fung, K.-P.; Zheng, Y.; Lee, S.M.-Y.; Wang, Y.-T. 2008: Anti-proliferative and pro-apoptotic effect of Smilax glabra Roxb. extract on hepatoma cell lines. Chemico-Biological Interactions 171(1): 1-14
Neels, P.; Bremer, H.; Brock, J.; Walzel, H. 1993: Anti-proliferative and signal-transducing activity of soluble beta-galactoside-binding S-type lectins. Biological Chemistry Hoppe-Seyler 374(9): 728
Ren, G.; Zhao, Y.-p.; Yang, L.; Fu, C.-x. 2008: Anti-proliferative effect of clitocine from the mushroom Leucopaxillus giganteus on human cervical cancer Hela cells by inducing apoptosis. Cancer Letters 262(2): 190-200
Park, J-Hee.; Lim, H.Joung.; Lee, K-Sook.; Lee, S.; Kwak, H-Jeong.; Cha, J-Heon.; Park, H-Young. 2008: Anti-proliferative effect of licochalcone A on vascular smooth muscle cells. Biological and Pharmaceutical Bulletin 31(11): 1996-2000
Sharma, V.; Kosmas, C.E.; Banka, V.S. 1995: Anti-proliferative effect of simvastatin on human coronary smooth muscle cells Comparison with lovastatin. Circulation 92(8): I18
Higo,H.; ZhangShiPing; HeLing; LiFu; LiuYan; CaiYunQing 2008: Anti-proliferative effects and induction of apoptosis by liquiritigenin in human hepatocellular carcinoma SMMC-7721 cells. Journal Of Traditional Medicines: 5 6, 160-165
Lewis, L.D.; Strawbridge, R.R.; Mcquilkin, S.H. 1998: Anti-proliferative effects of 23-dideoxycytidine in human pancreatic tumor cells. Journal of Investigative Medicine 46(3): 213a, Ch
Lee, D.K.; Jang, S.; Kim, M.J.; Kim, J.H.; Chung, M.J.; Kim, K.J.; Ha, N.J. 2008: Anti-proliferative effects of Bifidobacterium adolescentis SPM0212 extract on human colon cancer cell lines. Bmc Cancer 8: 310
Ide, S.I.; Kondoh, M.; Satoh, H.; Karasawa, A. 1994: Anti-proliferative effects of benidipine hydrochloride in porcine cultured vascular smooth muscle cells and in the rats subjected to balloon-catheter-induced endothelial denudation. Japanese Journal of Pharmacology 64(Suppl 1): 246P
Kang, S.C.; Lee, C.M.; Choung, E.S.; Bak, J.P.; Bae, J.J.; Yoo, H.S.; Kwak, J.H.; Zee, O.P. 2008: Anti-proliferative effects of estrogen receptor-modulating compounds isolated from Rheum palmatum. Archives of Pharmacal Research 31(6): 722-726
Banner, K.H.; Page, C.P. 1997: Anti-proliferative effects of forskolin, dibutyryl cAMP and PGE2 are not affected by the cyclooxygenase inhibitor, indomethacin. European Respiratory Journal Suppl 10(25): 443S
Tjuvajev, J.; Kolesnikov, Y.; Joshi, J.R.; Zhou, Y.; Kreek, M.J.; Blasberg, R. 1996: Anti-proliferative effects of human corticotropin releasing factor in W256 cells The role of NO second messenger pathway. Proceedings of the American Association for Cancer Research 37: 229
Hempstock, J.; Kavanagh, J.P.; George, N.J.R. 1997: Anti-proliferative effects of phytoestrogens on human prostatic cell lines. Journal of Urology 157(4 Suppl): 141
Yatsu, F.M.; Ranganna, K. 1996: Anti-proliferative effects of sodium butyrate. Official Gazette of the United States Patent and Trademark Office Patents 1191(2): 1131
Grimble, A.; Lessof, M.H. 1965: Anti-Prostate Antibodies in Arthritis. British Medical Journal 2(5456): 263-264
Scheffler, S.; Feist, E.; Kuckelkorn, U.; Doerner, T.; Doenitz, H.; Kordonouri, O.; Hiepe, F.; Kloetzel, P.M.; Burmester, G.R. 1998: Anti-proteasome autoantibodies represent specific diagnostic markers for autoimmune myositis and SLE. Arthritis and Rheumatism 41(9 Suppl): S254
Franssen, C.F.M.; Huitema, M.G.; Muller Korbold, A.C.; Limburg, P.C.; Kallenberg, C.G.M.; Cohen Tervaert, J.W. 1998: Anti-proteinase 3 ANCA are better activators of neutrophils in vitro anti-myeloperoxidase ANCA. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 455A
D.B.ndt, M.; Meyer, O.; Dacosta, L.; Elbim, C.; Pasquier, C. 1998: Anti-proteinase-3 antibodies recognize various targets on the HUVEC membrane. Arthritis and Rheumatism 41(9 Suppl): S116
Desassis, J.F.; Van Den Born, J.; Berden, J.H.M. 1992: Anti-proteinuric effect of cyclosporin A in adriamycin nephropathy in the rat. Nephrology Dialysis Transplantation 7(7): 671
De Groot, P.G.; Horbach, D.A.; Simmelink, M.J.; van Oort, E.; Derksen, R.H. 1998: Anti-prothrombin antibodies and their relation with thrombosis and lupus anticoagulant. Lupus 7(Suppl 2): S32-S36
Reverter, J.C.; Munoz, F.J.; Tassies, D.; Font, J.; Cervera, R.; Lopez Soto, A.; Escolar, G.; Ingelmo, M.; Ordinas, A. 1998: Anti-prothrombin antibodies in patients with the anti-phospholipid syndrome. British Journal of Haematology 102(1): 249
Ordi Ros, J.; Josefina, P.; German, D.; Julieta, V.; Francisco, M.; Olga, R. 1996: Anti-prothrombin antibody by ELISA in a patient with lupus anticoagulant. Lupus 5(5): 543
Cakir, B.; Rivadeneira, A.C.; Hayes, P.M.; Ortel, T.L.; Petri, M.; Roubey, R.A.S. 1998: Anti-prothrombin autoantibodies Detection and characterization. Lupus 7(Suppl 2): S219
Horbach, D.A.; Van Oort, E.; Derksen, R.H.W.M.; De Groot, P.G. 1998: Anti-prothrombin-antibodies with LAC-activity inhibit tenase, prothrombinase and protein C activity by increasing the affinity of prothrombin for phospholipids. Lupus 7(Suppl 2): S208
Iwalewa, E.O.; Omisore, N.O.; Adewunmi, C.O.; Gbolade, A.A.; Ademowo, O.G.; Nneji, C.; Agboola, O.I.; Daniyan, O.M. 2008: Anti-protozoan activities of Harungana madagascariensis stem bark extract on trichomonads and malaria. Journal of Ethnopharmacology 117(3): 507-511
Lambert, L.H.Jr 1997: Anti-protozoan methods. Official Gazette of the United States Patent and Trademark Office Patents 1200(2): 1278
Taylor, E.J.; Evans, F.J. 1998: Anti-psoriatic action of lutein demonstrated by inhibition of rat photodermatitis. Journal of Pharmacy and Pharmacology 50(Suppl ): 78
Vasa, M.; Peus, D.; Beyerle, A.; Pott, M.; Vasa, R.; Pittelkow, M. 1998: Anti-psoriatic drug anthralin activates EGF receptor/ERK and p38 signaling pathways via reactive oxygen species. Journal of Dermatological Science 16(Suppl 1): S205
Olney, J.W.; Farber, N.B.; Price, M.T.; Labruyere, J.; Nemnich, J.; Peter, H.S. 1993: Anti-psychotic agents prevent NMDA antagonist neurotoxicity. Society for Neuroscience Abstracts 19(1-3): 1697
Sainz, A. 1961: Anti-psychotic spectrum of proketazine. Diseases of the Nervous System 22: 585-589
Dibie, A.; Musset, D. 1996: Anti-pulmonary embolism filter. Official Gazette of the United States Patent and Trademark Office Patents 1188(1): 304
Dibie, A.; Musset, D.; Prou, P.; Catteau, G. 1995: Anti-pulmonary embolism filter and corresponding presentation and fitting kit. Official Gazette of the United States Patent and Trademark Office Patents 1174(2): 1032-1033
Skelton, F.; Shute, E.; Skinner, H.G.; Waud, R.A. 1946: Anti-purpuric action of a-Tocopherol. Science 103(2687): 762
Borovsky, M.P. 1960: Antipyretic activity of acetylsalicylic acid and salicylamide suspension in pediatrics. A comparative clinical evaluation in two hundred six cases. American Journal of Diseases of Children 100: 23-30
Tijani,A.Y.; Uguru,M.O.; Salawu,O.A. 2008: Anti-pyretic, anti-inflammatory and anti-diarrhoeal properties of Faidherbia albida in rats. African Journal Of Biotechnology: 6, 696-700
Koseki, H. 1996: Anti-quail Pax-1 antibody. Hybridoma 15(1): 99
Stephens, E.D. 1935: Anti-rabic immunization probable lines of progress in improvement of methods. Indian Journal of Medical Research: 537-556
Remlinger, P.; Bailly, J. 1930: Anti-rabic vaccination of animals, and of the dog in particular, in Morocco, 1929. REV VET ET JOUR MED VET ET ZOOTECH 82(July): 371-377
Mazzini, C.A. 1959: Anti-rabies serum of high titer II Divisions into fractions for purification and concentration Chemical and electrophoretical studies. Rev Fac Agron Y Vet: 462-473
Crescini, A.C. 1959: Anti-rabies serums of high titer I Preparation, titration, experimental application, and in human medicine. Rev Fac Agron Y Vet: 445-461
Konieff, D.; Ramsine, S. 1928: Anti-rabies vaccination with formol vaccine. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 99: 1259-1261
Heubner, W. 1929: Anti-rachitic action and effect upon the arteries of irradiated ergosterol. Klin Wochenschr 8(9): 407-408
E.M. 1931: Anti-rachitic effect of seal fat. 6image 3image repts Astrakhan Volgo Caspian Sea Scientific Fisheries Sta 7(4): 72-74
Carlson, C.W.; Mcginnis, J.; Jensen, L.S. 1964: Anti-Rachitic effects of Soybean Preparations for Turkey Poults. Journal of Nutrition 82(3.): 366-370
Yuile, C.L.; Chen, P.S.; Bosmann, H.B. 1967: Antirachitic sterols in chicks. Rachitic bone lesions in chicks after multiple graded doses of vitamin D and dihydrotachysterols. Archives of Pathology 83(3): 241-250
Barabol, V.A. 1964: Anti-radiation action of gallates at doses of 1000 roentgens. Fiziol Zh Akad Nauk Ukr Rsr 10(1): 89-93
Baraboi, V.A.; Medovar, B.Y. 1963: Anti-radiation and antioxidant properties of some polyphenols. Ukrayins K Biokhim Zhur 35(6): 924-930
Arenberger, P.; Nelson, P.; Abraham, A.; Leder, R.O. 1993: Anti-rantes immunoreactivity in skin. Journal of Investigative Dermatology 101(3): 446
Votta, B.J.; Bertolini, D.R. 1994: Anti-rat IL-1-alpha and IL-1 receptor antagonist differentially inhibit resorption stimulated by a variety of agents in fetal rat long bone cultures. Bone and Mineral 25(1): S53
Morgan, A.C.Jr 1997: Anti-receptor and growth blocking antibodies to the vitamin B-12/transcobalamin II receptor and binding sites. Official Gazette of the United States Patent and Trademark Office Patents 1204(3): 2133
Strosberg, A.D. 1992: Anti-receptor antibodies as ligands. Hulme, E C Practical Approach Series; Receptor-ligand interactions: 19-36
Fu, M.L.X.; Wallukat, G.; Matsui, S.; Teraoka, K.; Murakami, E.; Hjalmarson, A. 1998: Anti-receptor antibodies from rabbits with cardiomyopathy. Journal of Molecular and Cellular Cardiology 30(6): A26
Hobden, J.A.; Gupta, S.K.; Masinick, S.A.; Wu, X.; Kernacki, K.A.; Berk, R.S.; Hazlett, L.D. 1996: Anti-receptor antibodies inhibit P aeruginosa binding to the cornea and prevent corneal perforation. IOVS Investigative Ophthalmology and Visual Science 37(3): S209
Adamus, G.; Amundson, D.; Machnicki, M. 1997: Anti-recoverin antibodies cause apoptotic death of photoreceptor cells in vivo. IOVS Investigative Ophthalmology and Visual Science 38(4 Part 1-2): S529
Machnicki, M.; Fox, D.A.; Adamus, G. 1998: Anti-recoverin antibody induces photoreceptor and bipolar cell apoptosis. IOVS Investigative Ophthalmology and Visual Science 39(4): S363
Aptsiauri, N.; Jordan, B.L.; Heckenlively, J. 1998: Anti-recoverin immunoreactivity in patients with retinal degeneration without systemic malignancy. IOVS Investigative Ophthalmology and Visual Science 39(4): S363
Nisitani, S.; Murakami, M.; Honjo, T. 1997: Anti-red blood cell immunoglobulin transgenic mice. An experimental model of autoimmune hemolytic anemia. Annals of the new York Academy of Sciences 815: 246-252
Flaherty, J.; Lawlor, P.; Byrne, P.J.; Walsh, T.N.; Hennessy, T.P.J. 1996: Anti-reflux surgery Its role in bile reflux. Gastroenterology 110(4 Suppl): A108
Govil, Y.; Katz, P.; Srinivasan, R.; Khoury, R.; Castell, D. 1998: Anti-reflux therapy improves symptoms in patients with reflux laryngitis. Gastroenterology 114(4 Part 2): A138
Mesrobian, H G.O.; Roemer, F.D. 1997: Anti-reflux ureteral stent. Official Gazette of the United States Patent and Trademark Office Patents 1200(3): 1958
Patzer, C.R. 1996: Anti-reflux valve with environmental barrier. Official Gazette of the United States Patent and Trademark Office Patents 1192(4): 2721
Trifonova, I.V.; Tsvetkova, L.N.; Shcherbakov, P.L.; Nechaeva, L.B. 1994: Anti-relapse therapy of children with duodenal peptic ulcer. Pediatriya (Moscow) 1994(1): 46-49
Filin, V.A.; Tsvetkova, L.N.; Trifonova, I.V.; Lobanov, Y.F. 1994: Anti-relapse treatment of duodenal ulcer in children. Rossiiskii Vestnik Perinatologii i Pediatrii 39(3): 28-32
McDonald, K.M. 1995: Anti-remodeling effects of ACE inhibitors. Coronary Artery Disease 6(4): 295-301
Moriconi, L.; Rizzo, G.; Pasquariello, A.; Innocenti, M.; Falbo, E.; Cioni, L.; Migliorini, P.; Dolcher, M.P. 1995: Anti-renal antibodies in transplant glomerulopathy. Nephrology Dialysis Transplantation 10(6): 1069
Lyons, J.G.; Chambon, P. 1995: Anti-repression and direct activation are distinct properties of GAL4-VP16. Journal of Cellular Biochemistry Suppl 1995(21B): 160
Sterk, G. 1992: Anti-resistance strategies against the red spider mite, Panonychus ulmi in Belgian orchards. Otto, D, Weber, B Insecticides: Mechanism of action and resistance: 427-432
Barnard, D.L.; Sidwell, R.W.; Matheson, J.E.; Xiao, W.; Player, M.; Torrence, P.F. 1997: Anti-respiratory syncytial virus activity of 2-5a antisense oligonucleotide chimeras. Antiviral Research 34(2): A89
Barnard, D.L.; Sidwell, R.W.; Gage, T.L.; Okleberry, K.M.; Matthews, B.; Holan, G. 1997: Anti-respiratory syncytial virus activity of dendrimer polyanions. Antiviral Research 34(2): A88
Taylor, G.; Porter, T.; Dillon, S.; Trill, J.; Ganguly, S.; Hart, T.; Davis, C.; Wyde, P.; Tempest, P.; Harris, W. 1995: Anti-respiratory syncytial virus monoclonal antibodies show promise in the treatment and prophylaxis of viral disease. Biochemical Society Transactions 23(4): 1063-1067
Pomerat, C.M.; Anigstein, L. 1944: Anti-Reticular Immune Serum: its Action Demonstrated by Tissue Culture Technique. Science 100(2603): 456
Sears, J.E.; Buck, M.; Weitzman, M.; Sears, M.L. 1996: Anti-retinal antibodies in a paraneoplastic retinopathy. IOVS Investigative Ophthalmology and Visual Science 37(3): S535
Heckenlively, J.R.; Aptsiauri, N.; Hargrave, P.A. 1996: Anti-retinal protein antibodies are significantly present in cases of cystoid macular edema with retinitis pigmentosa. IOVS Investigative Ophthalmology and Visual Science 37(3): S667
Gallicchio, V.S.; Mayhew, C.; Oakley, O.R.; Hughes, N.K.; Piper, J.; Elford, H.L. 1996: Anti-retroviral activity of ribonucleotide reductase inhibitors Didox and Trimidox in a murine acquired immunodeficiency model either alone or in combination with DDI. Experimental Hematology 24(9): 1095
Reichelderfer, P.S.; Coombs, R.W. 1995: Anti-retroviral drug resistance as a modifier of the interaction between viral load and CD4+ cell decline. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 10(Suppl 3): S17-S18
Gompels, M.; Johnson, N.; Parkin, J.; Nye, K. 1996: Anti-retroviral drugs cause sequential effects on CD4 counts, apoptosis and inositol signalling. AIDS (London) 10(Suppl 2): S43
Naesens, L.; Bischofberger, N.; Armilli, M.; Kim, C.; De Clercq, E. 1997: Anti-retrovirus activity and pharmacokinetics in mice of bi -PMPA, the bis oral prodrug of PMPA. Antiviral Research 34(2): A50
Lorini, R.; Cortona, L.; Scaramuzza, A.; Achilli, G.; Cattaneo, E.; Ferrante, P.; Severi, F. 1993: Anti-retrovirus antibodies in insulin-dependent diabetic children at diagnosis and during 1-26 yrs follow-up. Pediatric Research 33(5 Suppl): S75
Ikesue, A.; Deguchi, Y.; Taniguchi, Y. 1996: Anti-rheumatic effects of HAI-106, a novel phenyl propionic acid derivant. Japanese Journal of Pharmacology 71(Suppl 1): 306P
Nakamura, H.; Yoshino, S.; Nagashima, M.; Yoshioka, T.; Hirai, H.; Matsuzaki, T. 1998: Anti-rheumatic effects of synovectomy Three years follow-up study of multiple synovectomy for refractory RA. Arthritis and Rheumatism 41(9 Suppl): S314
Goode, J.D. 1993: Anti-rheumatic treatment in the elderly. Zeitschrift für Gerontologie 26(1): 39-43
Liu, M.; Dai, Y.; Yao, X.; Li, Y.; Luo, Y.; Xia, Y.; Gong, Z. 2008: Anti-rheumatoid arthritic effect of madecassoside on type Ii collagen-induced arthritis in mice. International Immunopharmacology 8(11): 1561-1566
Wax, M.B.; Li, Z.; Barrett, D.A.; Pestronk, A.; Romano, C. 1995: Anti-rhodopsin antibodies in patients with normal pressure glaucoma. IOVS Investigative Ophthalmology and Visual Science 36(4): S218
Gonzalez, C.M.; Lopez Longo, F.J.; Grau, R.; Rodriguez Mahou, M.; Monteagudo, I.; Escalona, M.; Gonzalez, M.; Moreno, A.C.; Carreno, L. 1994: Anti-ribonucleoprotein antibodies in children with human immunodeficiency virus infection and systemic lupus erythematosus. European Journal of Clinical Investigation 24(Suppl 2): A28
Petri, M. 1996: Anti-ribosomal P antibodies in SLE A prospective cohort study. Arthritis and Rheumatism 39(9 Suppl): S292
Press, J.; Palayew, K.; Elkon, K.; Laxer, R.M.; Eddy, A.; Rakoff, D.; Silverman, E.D. 1994: Anti-ribosomal P antibodies in pediatric systemic lupus erythematosus. Arthritis and Rheumatism 37(9 Suppl): S318
Argirova, T.; Petrova, T.; Monova, D. 1998: Anti-ribosomal P antibodies in systemic lupus erythematosus A case control study correlating renal disease. Nephrology Dialysis Transplantation 13(6): A30
Stafford, H.A.; Anderson, C.J.; Chen, A.E. 1993: Anti-ribosomal P autoantibodies bind to T lymphocyte surfaces. Arthritis and Rheumatism 36(9 Suppl): S236
Pan, Z.J.; Stafford, H.A. 1997: Anti-ribosomal P autoantibodies in healthy adults are masked by anti-idiotypes. Arthritis and Rheumatism 40(9 Suppl): S83
Isshi, K.; Kikuchi, H.; Hirohata, S. 1998: Anti-ribosomal P protein antibodies induce the expression of vascular cell adhesion molecule-1 on human umbilical vein endothelial cells. Arthritis and Rheumatism 41(9 Suppl): S68
Bader, M.N. 1946: Anti-rickettsial activity of para-aminobenzoic acid Effect of PABA on experimental spotted fever. Texas Repts Biol And Med: 260-278
Seong, S.Y.; Kim, I.S.; Choi, M.S.; Chang, W.H. 1994: Anti-rickettsial immunity induced by recombinant Bor56 protein of Rickettsia tsutsugamushi expressed by Escherichia coli. Abstracts of the General Meeting of the American Society for Microbiology 94: 152
Rogers, D.P. 1998: Anti-rotational connecting mechanism. Official Gazette of the United States Patent and Trademark Office Patents 1208(2): 1182
Velazquez, F.R.; Matson, D.O.; Calva, J.J.; Ruiz Palacios, G.M.; Estes, M.K.; Pickering, L.K. 1993: Anti-rotavirus IgA antibody status in a cohort of Mexican children monitored from birth to 2 years of life. Pediatric Research 33(4 Part 2): 186A
Azuma, M.; Hoq, M.M.; Hisaki, M.; Imabori, H.; Ohta, Y.; Kawanishi, K.; Suzutani, T.; Ogasawara, M. 1996: Anti-rotavirus activity of pyrimidine derivatives. Antiviral Research 30(1): A38
Lusher, J.M.; Zuelzer, W.W.; Parsons, P.J. 1966: Anti-s hemolytic disease: a case report. Transfusion 6(6): 590-591
Albrey, J.A.; Simmons, R.T. 1958: Anti-s of the MNSs blood group system. Medical Journal of Australia 45(19): 630-633
Crawford, T.J.; Sharma, T.; Lech, S.; Puri, B.K.; Kennard, C.; Murray, R.M.; Lewis, S.W.L. 1996: Anti-saccade abnormality in familial schizophrenic patients and first-degree relatives The Maudsley family study. Schizophrenia Research 18(2-3): 215
MehdiMaqbool; Malik,A.U. 2008: Anti-sap chemicals reduce sapburn injury and improve fruit quality in commercial mango cultivars. International Journal Of Agriculture And Biology: 1, 1-8
Ferguson, M.W.J.; Foreman, D.M.; Shah, M. 1997: Anti-scarring compositions comprising growth factor neutralizing antibodies. Official Gazette of the United States Patent and Trademark Office Patents 1202(1): 358
Cramer, T. 1963: Anti-Schoolchild-Smoking Campagin in Denmark. Acta - Unio Internationalis Contra Cancrum 19: 935-936
Mason, K.V. 1996: Anti-seborrhoeic formulation. Official Gazette of the United States Patent and Trademark Office Patents 1188(3): 2089
Opdyke, D.L.; Burnett, C.M.; Brauer, E.W. 1967: Anti-seborrhoeic qualities of zinc pyrithione in a cream vehicle. II. Safety evaluation. Food and Cosmetics Toxicology 5(3): 321-326
Brayden, D.J.; Moriarty, D.; Baird, A.W. 1996: Anti-secretory actions of loperamide require access to the basolateral side of rat colonic mucosae. Pharmaceutical Research (New York) 13(9 Suppl): S246
ShahabuddinBahmani; Harish,M.S.; MajidIqbal; Rao,K.S. 2008: Anti-secretory and anti-ulcer activity of Surasa, a poly herbal formulation in pylorus ligated rat model. Biosciences, Biotechnology Research Asia: 1, 295-300
Xia, H.H.X.; Kalantar, J.; Eslick, G.D.; Wyatt, J.M.; Adams, S.; Cheung, K.; Talley, N.J. 1998: Anti-secretory drugs increase corpus gastritis but only in the presence of Helicobacter pylori infection. Gastroenterology 114(4 Part 2): A335
Butterfield, I.; Sandle, G.I.; Higgs, N.B.; Warhurst, G. 1997: Anti-secretory effect of nicardipine in mammalian intestine may reflect direct inhibition of basolateral K+ channels. Gastroenterology 112(4 Suppl): A352
Taylor, C.T.; Moriarty, D.V.; Skelly, M.M.; O'donoghue, D.P.; Baird, A.W. 1995: Anti-secretory effects of berberine in human colonic epithelium. Gastroenterology 108(4 Suppl): A331
Wannang,N.N.; Anuka,J.A.; Kwanashie,H.O.; Gyang,S.S.; Auta,A. 2008: Anti-seizure activity of the aqueous leaf extract of Solanum nigrum Linn in experimental animals. African Health Sciences: 2, 74-79
Russell, R.N.; Cavus, I.; Teyler, T.J. 1997: Anti-seizure properties of the amine modified protein alpha-2-macroglobulin. Society for Neuroscience Abstracts 23(1-2): 808
Lefer, A.M. 1996: Anti-selectin therapy attenuates neutrophil-mediated ischemia-reperfusion and shock-induced tissue injury. Okada, K, Ogata, H International Congress Series; Shock: from molecular and cellular level to whole body: 15-22
Payne, D.; Jutila, M.; Kubes, P. 1995: Anti-selectin therapy reduces ischemia/reperfusion-induced microvascular dysfunction independent of leukocyte infiltration. FASEB Journal 9(3): A420
Kusumoto, T.; Ichikawa, S.; Asaka, K.; Sato, K.I.; Hiyama, T. 1995: Anti-selective alkylation of carboxylate enolates with 2-sulfonyloxyalkanes A new route to optically active 2-arylalkanoic acids. Tetrahedron Letters 36(7): 1071-1074
Kobayashi, S.; Kawasuji, T. 1994: Anti-selective asymmetric aldol reactions Enantioselective synthesis of anti-alpha,beta-dihydroxy phenyl ester derivatives. Tetrahedron Letters 35(20): 3329-3332
Berkowitz, L. 1959: Anti-semitism and the displacement of aggression. Journal of Abnormal and Social Psychology 59: 182-187
Hamdane, M.; David Cordonnier, M.H.; Preudhomme, C.; D'halluin, J.C. 1996: Anti-sense ODN against P65-NFKB inhibited transformation of myeloid cells by P210BCR/ABL. Blood 88(10 Suppl 1 Part 1-2): 207A
Johnson Flanagan, A.M.; Singh, J.; Robert, L.S.; Morissette, J.C.P. 1998: Anti-sense RNA for cab transcript to reduce chlorophyll content in plants. Official Gazette of the United States Patent and Trademark Office Patents 1211(5): 5118
Khanna, A.; Li, B.; Li, P.; Stenzel, K.H.; Suthanthiran, M. 1993: Anti-sense TGF-beta oligonucleotides rescue mammalian cells from CsA-associated cell cycle arrest. Journal of the American Society of Nephrology 4(3): 913
Taylor, A.D.; Flower, R.J.; Buckingham, J.C. 1997: Anti-sense and immunoneutralisation studies reveal a role for lipocortin 1 in the control of growth hormone in vivo and in vitro. British Journal of Pharmacology 120(Proceedings Suppl ): 345P
Kilpatrick, M.W.; Phylactou, L.A.; Velinov, M.; Wu, C.H.; Wu, G.Y.; Tsipouras, P. 1994: Anti-sense based down-regulation of the fibrillin 15 gene product. Clinical Research 42(2): 202A
Bhattacharya, R.; Marchant, J.; Young, B.; Birk, D.E.; Doane, K.J. 1996: Anti-sense beta-1 integrin perturbs interactions of corneal fibroblasts and periocular mesenchyme cells with fibronectin and tenascin. Molecular Biology of the Cell 7(Suppl ): 426A